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INTRODUCTION 
 
During the current decade organocatalysis1 has met an unprecedented interest. Although 
the idea of using substoichiometric amounts of organic molecules to promote chemical 
transformations may look obvious and reminiscent of the natural activity of many 
enzymes, only few, scattered reports appeared in this field before that List and Barbas2 
showed proline´s ability to catalyze the asymmetric intermolecular aldol reaction. While 
up to that date the attention had been largely reserved to metal containing catalysts, it is 
clear that the use of organocatalysts presents some interesting advantages; as they are 
more robust and inexpensive than most metal-ligand complexes and they allow us to 
bypass the toxicity issues that limit the use of metal containing catalysts, for instance, in 
the pharmaceutical industry. 
 
Organocatalysis, development and classification  
 
In 1960, Pracejus3 was the first to report the use of an enantioselective organocatalyst, 
showing that 1% of quinidine was able to promote the transformation of ketenes in 
optically active (ee: 60%) α-phenyl-propionic acid esters (scheme 1); in the seventies, the 
remarkable properties of proline as organocatalyst where explored for the first time in 
the intramolecular aldol reaction by Eder, Sauer, Weichert4 and Hajos, Parrish5 (scheme 
2). 
 
 
Scheme 1. The asymmetric, organocatalytic, synthesis of α-phenyl propionic acid esters proposed by Pracejus in 1960 
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Scheme 2. The first organocatalytic, proline promoted, aldol reaction. 
 
Other examples were reported for the diketopiperazines catalyzed synthesis of 
cyanhydrins6, in the Thiazolium catalyzed benzoin and Stetter reactions7 and in the 
ketones-catalyzed epoxidation8. Some important, non-enantioselective catalysts were 
developed such as DMAP, for acyl transfer reactions9 and TEMPO, for alcohol oxidation10, 
but it was the discovery of proline as an efficient catalyst for the asymmetric 
intermolecular aldol reaction that paved the way for organocatalysis to become one of 
the most challenging and studied fields of this century2 (scheme 3). 
 
 
Scheme 3. The Intermolecular aldol reaction is effectively catalyzed by proline 
 
A rational method to classify the different kinds of organocatalysts may be represented 
by analyzing their mechanism of action; in this way, we can divide them in four families: 
Lewis base- and Lewis acid catalysts, Brönsted base- and Brönsted acid catalysts. 
Lewis base catalysts promote the target reaction by building an activated intermediate 
through a step of nucleophilic addition of the catalyst to the substrate. One important 
example in this field is represented by the DMAP catalyzed acetylation of alcohols which 
proceeds through an activated acylpyridium complex9g (scheme 4). This discovery 
prompted the preparation of chiral Lewis base organocatalysts aimed to carry out 
selective acetylations for the kinetic resolution of alcohols11, esterification of carboxylic 
acids12 or meso-anhydride desymmetrization13. 
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Scheme 4. DMAP catalyzed alcohols acylation. 
 
Two other fundamental catalytic processes may be included in this family: imminium- and 
enamine-based catalysis. In the first case we observe the formation of a reversible 
imminium intermediate between the catalyst and the substrate, whose enhanced 
electrophilicity accelerates the reaction with a nucleophile. The catalyst is regenerated by 
hydrolysis of the imminium intermediate (scheme 5, above). An older example of this 
kind of process is represented by the Knoevenagel reaction; in the last few years 
MacMillan, Jorgensen, Wang, Miller, List and many others showed that chiral amines 
could work as effective organocatalysts in the Diels-Alder reaction14, Friedel-Crafts 
alkylation15, conjugated addition16 and cycloadditions17 (scheme 5, below). 
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Scheme 5. Mechanism of the imminium catalysis (above); applications of McMillan´s catalyst in the Diels-Alder reaction 
and in the conjugated addition (below) 
 
Enamine catalysis may be regarded as a special case of the imminium catalysis, in which 
the imminium intermediate between a secondary amine and a carbonyl compound, 
having an acid α-proton, evolves to an enamine18 intermediate which, through a 
nucleophilic attack on the aldol substrate, leads to the formation of an imminium cation. 
This is successively hydrolyzed to regenerate the catalyst, as we can see for instance in 
the case of the proline catalyzed aldol reaction (scheme 6). Enamine catalysis, whose 
mechanism is reminiscent of the natural activity of the Lys 229 residue in the active site of 
type I aldolases19, is of enormous importance for some of the most profusely studied 
reactions in the last years and will be analyzed later in detail.  
 
 
Scheme 6. Mechanism the enamine catalysis. 
 
Lewis acid catalysis is generally related to metal containing catalysts, but a good example 
in the field of organocatalysis is represented by the ketone catalyzed epoxidation of 
olefines. In this process, the ketone acts as a Lewis acid and following the nucleophilic 
attack of the anion peroxymonosulfate, a dioxiran is built as oxidizing agent. Similarly, in 
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the Shi-epoxidation8, a chiral ketone derived from fructose acts as a selective epoxidation 
organocatalyst. 
Brönsted base catalysis proceeds through a deprotonation step which activates the 
substrate for the desired reaction. A nice asymmetric organocatalytic approach was 
proposed by Corey20 using a guanidine derivative to promote the asymmetric Strecker 
reaction (scheme 7, above). 
The last process of this classification, Brönsted acid catalysis, proceeds through a proton 
exchange between the catalyst and the substrate or by activation of the substrate 
through the formation of strong H-bonds. Excellent examples are represented by the use 
of TADDOL as a metal-free catalyst in the hetero-Diels-Alder reaction21 (scheme 7, center) 
or by the thiourea-based organocatalysts in a broad range of transformations22. Another 
example has been presented independently by Akiyama23 (scheme 7, below) and Terada24 
by developing chiral phosphates that can promote the asymmetric Mannich reaction, or 
by Sasai25 who conjugated the Brönsted acid potential of the BINOL unit with a second 
Lewis base functionality to prepare an effective catalyst for the aza-Morita-Baylis-Hilman 
reaction.  
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Scheme 7. Brönsted base catalyst proposed by Corey (above); Taddol as a Brönsted acid in the hetero-Diels-Alder 
reaction (center); Brönsted acid catalyst for the Mannich Reaction (below)  
 
In the next chapters of this thesis we will be concerned with reactions following the first 
mechanism of this classification, in particular we will speak about enamine catalysis. 
 
Enamine catalysis and proline 
 
The reversible formation of an enamine intermediate (scheme 6) represents a 
convenient, atom-economic catalytic pathway, and finds its roots in the chemistry of the 
preformed enamines pioneered by Stork26; it is comparable to the generation of a 
carbanion, but the catalyst is freed at the end of the catalytic cycle and does not require a 
stoichiometric load. Recently, a number of diverse, small molecules able to promote 
important asymmetric reactions through an enamine-based mechanism have been 
reported, including asymmetric aldol reaction1, Michael addition16f, conjugated 
addition16b,16c, Mannich reaction1a, α-halogenation27, α-hydroxylation28 and α-amination 
of aldehydes29, aza-Diels-Alder30 and aza-Morita-Baylis-Hilman31 (scheme 8). 
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Scheme 8. Examples of enamine-based organocatalysts. 
 
In 1999 L-proline was discovered as an effective catalyst for the intermolecular aldol 
reaction2. Since that time, an extensive study has been carried out to explore scope, 
limitations, reaction mechanisms and optimization of this catalyst. A deeper analysis of 
the mechanism18 of the aldol reaction between acetone and aldehydes, brought about 
the hypothesis that the catalytic process may involve a chair-like Zimmerman-Traxler 
transition state in which both functionalities of proline are involved in the step 
determining the enantioselectivity of the process: while the amino functionality forms a 
enamine intermediate with acetone, the carboxylic functionality directs the aldol 
acceptor through an H-bond and takes part to the proton exchange process, like a 
Brönsted acid co-catalyst. The minor product may arise from the second less stable 
transition state below or from a transition state in which the R group assumes a less 
favorable pseudo-axial position (fig. 1).  
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Fig. 1. Transition state models for the proline catalyzed aldol reaction. 
 
Proline proved to be a formidable catalyst for a number of processes, some of its greatest 
advantages being the fact that it is extremely versatile, environmentally friendly and also 
quite inexpensive. A large number of proline catalyzed aldol reactions have been 
reported1a,e, some noteworthy examples for the use of this catalyst in the aldol reaction 
are presented here (scheme 9):  
 
 
 
 
 
 
 Scheme 9. Examples of inter- and intramolecular aldol reactions effectively catalyzed by proline. 
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It is interesting to notice how proline allows us to obtain not only a high enantiomeric 
excess, but an excellent diasteromeric control is often achieved when in the direct 
intermolecular aldol reaction more then one new stereocenter is generated32, an effect 
that can be amplified in the case of the self-aldolization of the α-benzyloxyacetaldehyde 
to finally yield the hexose Allose with perfect enantioselectivity33. It performs well 
moreover in the Enolexo cyclizations34 as well as in the previously (scheme 2) reported 
Robinson annulations. 
The impressive results obtained in the aldol reaction are accompanied by a number of 
different other organocatalytic processes such as Mannich reaction1a, α-amination29, aza-
Diels-Alder30, aza-Morita-Baylis-Hillman31, all involving the enamine activation of the 
substrate in the transition state of the reaction (scheme 10). 
 
 
 
 
 
 
Scheme 10. Proline as a effective organocatalyst for the Mannich reaction, α-amination, aza-Diels-Alder and aza-Morita-
Baylis-Hillman. 
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Limitations 
 
Despite its advantages and high performances, the use of proline as organocatalyst meets 
some limitations. The high catalyst load that sometimes reaches 30-35% and is very 
seldom lower than 20% can surely be justified by its being quite inexpensive, especially if 
we think that the greatest majority of the organocatalysts developed in the last years as 
effective alternatives to proline have to be prepared through multistep synthesis 
procedures, generally involving modifications of the proline moiety itself; although being 
often more active, they are of course much more expensive than proline. A more 
stringent problem may be represented by the fact that proline performs better in DMSO 
and DMF, environmentally unfriendly and expensive solvents which imply generally a not 
trivial aqueous work up at the end of the reaction, exclude the possibility of recovering 
the catalyst and are not suitable for the use in a large or industrial scale. Moreover in the 
last few years, the idea of developing effective organocatalysts that are able to catalyze 
efficiently the aldol reaction in water, or better, in a heterogeneous water-substrates 
dispersion, has been blossoming due to the discovery that the organocatalyzed reaction 
between water-insoluble ketones and aldehydes is feasible, and proceeds well at the 
interface between the aqueous phase and the organic layer/droplets. In these conditions, 
and generally in presence of water, proline provides generally racemic products, thus 
limiting its use for this purpose. Finally, the search for new catalysts has been prompted 
by the desire of improving the yield, the selectivity and the speed of many processes for 
which proline resulted to be a unsatisfactory catalyst, some of such reactions, if we just 
limit ourselves to the field of the aldol reaction are reported in scheme 11.    
Although proline works generally well in the aldol reaction between aliphatic aldehydes 
and ketones, the results obtained in the case of aromatic aldehydes2 can be surely 
improved. Moreover, in the case of the Wieland-Miescher ketone, the results 
achieved4,5,35 were not as brilliant as in the case of its 5-member-ring analogue. Those 
results prompted a large number of researchers to propose new catalysts and to 
investigate the full spectrum of the aldol reaction. 
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Scheme 11. Examples of aldol reactions for which proline did not perform as a satisfactory catalyst. 
 
 
Development of new catalysts, the aim of this thesis 
 
The development of new catalysts has been following some main routes. On one hand 
attempts have been made to modify the scaffold of proline itself, generally, at the 
positions 3,3´ of the pyrrolidine ring. In this way, a more demanding steric factor was 
introduced and, at the same time, an increased solubility of the catalyst in the organic 
layer of the heterogeneous aldol reaction was obtained36. In a comparable way, other 
authors tried to create easily recoverable catalysts by linking hydroxyproline, for instance, 
to a polymeric support1g. Modification of the proline moiety at the C-terminus has 
brought to interesting results as well37 (scheme 12). 
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Scheme 12. Examples of new catalysts, prepared through modification of the proline moiety (57, 58, 59) or through its 
immobilization on a polymeric support (63 and 64). 
 
On the other hand, another general way of preparing new catalysts has been represented 
by coupling proline at its C-terminus with amino acids, amines or amino alcohols in order 
to build peptides or pseudo-peptides38. This idea, relies on the possibility that such 
catalysts, although maintaining an enamine-based mechanism of action, may present a 
more suitable spatial arrangement of the amino and carboxylic (or alternative hydrogen 
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bond donor) functionality in comparison with proline, thus inducing a better selectivity 
and yield in the aldol reaction (scheme 13). 
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Scheme 13. Di- and tripeptides prepared as effective catalysts for the aldol reaction. 
 
The development of these catalysts is made extremely challenging by the large number of 
diverse structures accessible through this strategy. If we simply restrict ourselves to the 
pool of the standard aminoacid, we may easily see that 20 dipeptides and 4000 
tripeptides having proline as N-terminal amino acid are available. An elegant and 
successful combinatorial approach to this topic (which led to the development of the 
extremely active catalyst 66) has been presented38n,39 (fig. 2), based on the preparation of 
co-immobilized substrate-tripeptide libraries. This notwithstanding, a more direct 
approach to catalyst design may be attempted by looking more in detail at the turn 
inducing properties of the natural and unnatural amino acids. If we compare the plausible 
transition state38d for an already known structure and for a “model” peptide catalyst, (fig. 
3) we see how the idea of building a tripeptide catalyst having, for instance, a turn 
inducing amino acid as a central building block, may look as a rational approach to the 
preparation of a new class of catalysts. 
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Fig. 2. Identification of an effective catalyst for the aldol reaction through preparation of a co-immobilized substrate-
peptide library.  
 
 
 
Fig. 3. Transition state for the aldol reaction catalyzed by Gong´s dipeptide and by a “model” peptide. 
 
Ideally such building block would induce a turned, H-bond stabilized secondary structure 
in the catalyst, thus organizing the carboxylic and amino functionalities of the peptide in 
an ideal spatial arrangement to effectively promote the asymmetric aldol reaction. We 
would like here to show that the cis-β-aminocyclopropanecarboxylic acids (β-ACC, 
scheme 14), whose properties, synthesis and behavior in the field of organocatalysis will 
be the object of the next chapters, represent ideal candidates for the preparation of such 
catalytic peptides. 
 
 
Scheme 14. The two β-ACC enantiomers as candidate building block for the synthesis of novel organocatalysts 
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CHAPTER 1: β-ACC as a useful building block for the synthesis of 
bifunctional organocatalysts 
 
The chemistry of the β-ACCs, conformationally constrained β-amino acids, (+)-69 and (-)-
69 scheme 14) has been broadly studied by Reiser et al. following the development of 
convenient strategies for the cyclopropanation of heterocyclic aromatic compounds40. It 
has been found that these β-amino acids have, amongst their features, the ability to 
stabilize secondary structures even in very short peptides or to induce functional β-turns. 
Here we would like to show how these characteristics make these molecules the ideal 
building blocks for the synthesis of bifunctional organocatalysts. 
 
1.1 β-ACCs- based peptides and foldamers 
 
The use of the β-ACCs in the synthesis of new functional peptides has shown the ability of 
these amino acids to behave as constraining, rigidifying factors. For instance, the 
substitution of two units of the C-terminal (25-36) portion of neuropeptide Y with two 
units of (+)-69 (fig. 4), produced a sequence able to bind with high affinity and selectivity 
to the receptor subtype Y1
41. This effect is probably due to the ability of this building block 
to impose restraints to the arrangement of the neighboring side chains that are essential 
for the subtype recognition, obtaining a result comparable to their incorporation in a 
cyclic structure. 
 
 
 
Fig. 4. The (+)-β-ACC containing sequence, able to bind with high affinity to the receptor subtype Y1  
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Further investigation involved the preparation of foldamers: oligopeptides able to show 
conformational propensity toward a well defined secondary structure. For many years, 
chemists and biochemists have been attracted by the exceptional correlations between 
the secondary structure of proteins and their function in living organisms, which are 
obviously linked by the way the amino acidic sequences fold to assume their active 
structures. This generated an intriguing quest toward the possibility of reproducing a 
folding pattern or even the active site of an enzyme or of an agonist, using a lower 
number of opportunely chosen amino acids, able to fold in the desired way. As a 
consequence, we may ask ourselves which is the shortest amino acidic sequence able to 
fold. Although it is know that 12 natural residues are necessary to obtain a stable 
secondary structure, during the nineties Gellman42 showed that using the β-amino acids 
trans-ACHC or trans-ACPC (fig. 5) to build β-homooligomers, this number could be 
reduced to 4-7 units, allowing the preparation of stable 14- or 12-helical conformations in 
methanol. Seebach43 showed that acyclic β-amino acids as well, could be used to induce 
stable secondary structures in short β-hexamers in polar organic solvents (fig. 5).   
 
 
 
Fig. 5. The β-amino acids used by Gellman and Seebach in the preparation of foldamers 
 
In the last few years the attention switched from the homooligomers to mixed sequences 
of α/β-amino acids. Such peptides often show a higher propensity to fold in stable helical 
structures, and allow us to enrich the chemistry of foldamers with the inexpensive, well 
assorted natural amino acids44. Reiser et al.45 reported the first systematic study of such 
peptides, using methanol as solvent. Several peptides were prepared alternating ▲ or ▼ 
with L-alanine residues (fig. 6). Looking at the correlation between non-consecutive 
residues through NOESY spectroscopy, it was documented how all the short peptides 
analyzed present a certain degree of helical behavior and while the ▲-containing 
peptides tend to interconvert between mixtures of conformers, the hepta- and nona- 
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peptides containing ▼ fold in a well defined 313-helix, confirmed by the presence of 
various i-i+3 NOESY contacts. 
 
 
Fig. 6. Short β-Acc containing peptides which showed a partial (right) and definite (left) folding propensity. 
 
In a comparable way Gellman46 used the ACPC unit to induce well defined, or inter-
converting α-helical structures in mixed α/β-octamers. 
 
1.1.1 β-ACCs and β-turns 
 
Another remarkable ability of the β-ACCs and other β-amino acids or β-amino acids 
patterns is the capacity to turn short sequences in to hairpin-shaped peptides, similarly to 
the way in which anti-parallel β-sheets are formed in nature. This is of particular interest 
in the field of molecular recognition and in the development of this thesis. One 
interesting example was provided by Seebach47 by synthesizing a β-tetramer able to 
mimic the hormone somatostatin in its binding to the relative human receptor; this β-
peptide could reproduce the turn crucial for its recognition at the binding site. An 
example of the β-amino acids ability to induce a reverse-turn when slipped between an α-
amino acids sequence, was presented again by Gellman48 who used two β-units to create 
a hairpin between complementary natural amino acids (fig. 7a). Reiser and Sewald49 
reported that the introduction of the β-ACC ▲ in a cyclic pentapeptide cyclo-(Arg-Gly-
Asp-▲-Val) instead of the previously used D-Phe, could confer additional rigidity and a 
secondary structure stabilization to this cycle, thus enhancing its ability in inhibiting the 
interaction between RGD containing receptors and integrines. Geometry calculations 
supported by bi-dimensional NMR studies, show that the β-ACC unit resides at the center 
of a pseudo-β-turn (fig. 7b).  
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Fig. 7. a) Gellman´s β-amino acids based hairpin, b) the β-ACC residing at the center of a pseudo β-turn in the cyclo-
(Arg-Gly-Asp-▲-Val) peptide and c) model, hairpin-like peptide as a candidate organocatalyst. 
 
On the basis of the reported observations it is not with haste to say that the β-ACCs may 
serve as useful building blocks for the synthesis of turned peptides like in fig. 7c, with the 
functional groups of the proline unit and of a third amino acid able to assume the suitable 
geometry for catalyzing the asymmetric aldol reaction (fig. 3). 
 
 
1.2 Synthesis of the cis-β-aminocyclopropanecarboxylic acids (β-ACCs) 
 
The synthesis of the β-ACCs units begins with the cyclopropanation of the inexpensive N-
Boc-pyrrole40a,b (71) through its reaction with methyl diazoacetate in the presence of 
copper (II) triflate and phenylhydrazine (scheme 15). This process is diastereoselective, 
providing only the exo diastereomer, having the methyl group oriented towards the 
convex face of the bicyclic structure, but it is not enantioselective, yielding a racemic 
product (rac-72)40b. The yield of this process is low, but the starting material, N-Boc-
pyrrole, may be quantitatively recovered and used for a new cycle, with an overall 
conversion of 60-70%. The kinetic resolution of this racemate can be successfully carried 
out on the gram scale using the enzyme lipase L-240b but this did not appear to be a 
convenient method for a larger scale preparation of the desired building block. A 
successful approach to the resolution of this mixture in a multigram scale (160 g) was 
b) a) c) 
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previously performed50 on a semi-preparative chiral simulated moving bed 
chromatographic unit and yielded a large amount of enantiomerically pure (+)-72 and (-)-
72. In the development of this work no resolution of this racemic mixture has been 
carried out, and (rac)-72 has been directly used for the successive steps, with the aim of 
attempting a resolution of the racemic β-ACC at a later stage, through the use of chiral 
bases or through its incorporation in dipeptides. 
 
 
 
Scheme 15. Boc-Pyrrole cyclopropanation to yield the racemic exo- product. 
 
The further steps leading to the target building block include its ozonolysis, oxidation of 
the aldehyde moiety, deformylation at the N-terminus, and benzylation of the free 
carboxylic functionality, furnishing the opportunely protected building block, in its 
racemic form (rac)-76 (scheme 16). 
 
 
Scheme 16. Synthesis of the racemic building block 
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An attempt to resolve compound (rac)-75 was carried out by reacting it with equivalent 
amounts of chiral bases in order to achieve a diastereomeric salt crystallization, which 
represents a common way to resolve chiral mixtures51 (scheme 17, table 1) of acid or 
basic organic compounds. 
 
      
Scheme 17. The diastereomeric salt crystallization attempt of 75 
 
 
Table 1. Diastereomeric salt crystallization of 75  
Base salt  aggregation 
form 
precipitate after 
crystallization
a 
αD
b
 of 75 after workup of 
the precipitate 
(-)-α-methyl 
benzylamine 
oil - - 
(-)-methyl 
ephedrine 
white solid oil - 
cinchonidine white solid white solid 0 
a
From a Hexane/EtOAc mixture, 
b
in MeOH. 
 
 
Unfortunately this attempt proved to be unsuccessful as only in the case in which 
cinchonidine was used as a chiral base, a precipitate was obtained from a Hexane/EtOAC 
mixture , but this salt, after workup, resulted again in the racemic mixture (rac)-75. For, 
this reason, we concluded to couple rac-76 with proline and to perform the separation of 
the two diastereomeric dipeptides. 
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1.3 Synthesis of dipeptides and diastereomer separation 
 
The synthesis of the dipeptide Boc-Pro-β-ACC-OBn (78) was carried out using the protocol 
developed40a,52 by Reiser et al. for the coupling of the building block (rac)-76 (scheme 18); 
the N-terminus of the β-ACC is deprotected with gaseous HCl and is used as a 
hydrochloric salt (rac)-76a to avoid the opening of the cyclopropane ring which takes 
place for this compound in the presence of the free amino functionality. 
 
 
Scheme 18. Synthesis of the diastereomeric mixture H-Pro-β-ACC-OBn 
 
Although a selective crystallization of 78 from Hexane/EtOAc mixtures was unsuccessful, 
it was noticed that a column chromatography separation on silica gel (DCM/MeOH 15:1) 
could be attempted on the Boc-deprotected derivative 79, leading to two different 
peptides 80 (Rf = 0.25) and 81 (Rf = 0.20), both isolated with a yield of 35-40%. 
Interestingly the fractions containing a mixture of the non-separated diastereomers could 
be recovered and eventually used in a successive diastereomer separation, thus 
improving the efficiency of the process. 
Zwicknagl
53 coupled separately Boc-proline with (+)-69 and (-)-69, being in this way able 
to prove that dipeptide 80 corresponds to H-Pro-(-)-β-ACC-OBn (H-Pro-▼-OBn) and that 
81 corresponds to H-Pro-(+)-β-ACC-OBn (H-Pro-▲-OBn), see scheme 19 and fig. 8. 
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Scheme 19. Silica gel separation of the two diastereomers of 79 and their subsequent Boc-protection 
 
Fig. 8. a), b) dipeptides Boc-Pro-▲-OBn and Boc-Pro-▼-OBn, as obtained by Zwicknagl after coupling with the 
enantiomerically pure β-ACC, compared to c) and d) obtained from the Boc-protection of the diastereomers separated 
through column chromatography on silica gel. 
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1.4 Synthesis of di- and tripeptides as organocatalysts 
 
As the chromatographic separation of 80 and 81 represented the only way in which it was 
possible to achieve diastereomerically pure material, all the peptides synthesized proceed 
from a combination of the Pro-▲ or Pro-▼ patterns with natural amino acids or short 
peptides. 80 and 81 could be directly deprotected at the carboxylic functionality to 
furnish dipeptide catalysts 84 and 89 (scheme 20 and fig. 9). The same deprotection step 
was carried out for peptides 82 or 83 in order to couple them with a third amino acid 
(scheme 21), thus generating the Boc-Pro-▲-AA-OBn and Boc-Pro-▼-AA-OBn patterns 
that could be subsequently deprotected to provide a family of catalysts having one of the 
β-ACCs as a central building block. 
 
 
Scheme 20. Dipeptide catalyts are readily available from benzyl deprotection of 81 or 80 
 
Scheme 21. Synthetic pathway to the tripeptides having a β-ACC unit as a central building block 
 
Another possibility is represented by the direct coupling of 80 and 81 at their N-terminus 
with another proline unit, thus generating the tripeptides H-Pro-Pro-▲-OH (95, fig. 9) and 
H-Pro-Pro-▼-OH (88, see scheme 22). These peptides diverge from the catalyst design 
previously suggested (fig. 3 and 7c), but in a similar way, the turn-inducing properties of 
the Pro-Pro moiety, together with rigidity of the β-ACCs were supposed to be able to 
place the N- and C- termini of the catalyst in the ideal spatial arrangement to effectively 
promote the asymmetric aldol reaction. 
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Scheme 22. Synthesis of the tripeptides having a β-ACC unit as C-terminal amino acid 
 
A complete overview of the di- and tripeptides synthesized following the above 
mentioned coupling strategies can be found in fig. 9: 
 
 
Fig. 9. Di- and tripeptides prepared following the previously mentioned coupling strategies. 
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The choice of the R side-chain (see scheme 21) in the case of the tripeptides having a β-
ACC unit as a central amino acid, is not trivial, as according to a pure combinatorial 
approach, twenty different peptides for each enantiomer of the β-ACCs should have been 
prepared and screened. Wennemers38n has presented the tripeptide H-Pro-Pro-Asp-NH2 
(66) as an effective catalysts for the aldol reaction; further analysis of this catalyst and of 
its analogs shows that the aspartic acid side-chain represents an ideal compromise 
between chain flexibility and length, thus playing a pivotal role in the catalytic process54. 
We decided to screen for this purpose the amino acids Asp and Glu as coupling partners 
for our dipeptide 85 (or its diastereomer containing the ▼ unit), wishing to identify in this 
way the right sequence able to work as an effective bifunctional catalyst. Moreover, by 
observing the structure of the model peptide (fig. 7c), we considered that it would have 
been interesting to prepare a peptide able to assume a cis configuration at the amide 
bond between the β-ACC unit and the C-terminal amino acid. Bearing in mind that 
proline, due to the secondary amine nature of its N-terminus, is the natural amino acid 
presenting the highest probability (5 to 50%) to be found in a cis peptide bond55, we 
decided to include it in the pool of the coupling partners for the synthesis of novel 
catalysts. 
 
1.5 Tripeptides not containing the β-ACC units 
 
Another tripeptide containing an unnatural amino acid other than the β-ACC as a central 
building block was prepared in order to prove the importance and role of the rigid 
cyclopropane ring. For this purpose the H-Pro-β-Ala-Pro-OH (97) sequence was prepared, 
with β-alanine representing the conformationally unlocked equivalent the β-ACCs 
(scheme 23).  
 
Scheme 23. Synthesis of the tripeptide H-Pro-β-Ala-Pro-OH 
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1.6 Synthesis of tetra- and pentapeptides 
 
The elongation of the tripeptide moiety may be regarded as a way to obtain longer 
sequences able to assume a well defined secondary structure, thus approaching the 
concept of foldamers. Although the idea of using a well folded peptide as an 
organocatalyst may look extremely suggestive (it could be comparable to the preparation 
of an artificial enzyme) it meets some limitations from a practical point of view: such a 
catalyst would be much more expensive and laborious to prepare than proline or even 
than a relatively simple tripeptide. Considering the remarkable results obtained in the 
field of organocatalysis when simple amino acids and dipeptides have been employed, it 
would be hard to prove the convenience of such catalysts, even in the case of an 
outstanding catalytic performance. This notwithstanding, it appeared interesting to look 
for a correlation between an increased structural rigidity and an improved catalytic 
behavior. For this reason, two tetrapeptides (H-Pro-▲-Pro-▼-OH (101) and the H-Pro-▼-
Pro-Pro-OH (104) and the pentapeptide H-Pro-▲-Pro-▲-Pro-OH (106) were easily 
prepared, coupling preformed, diastereomerically pure, di- and tripeptides (scheme 24). 
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Scheme 24. Synthesis of tetrapeptides 101 and 104 and of pentapeptide 106, by coupling preformed di- and tripeptides 
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CHAPTER 2: Organocatalysis 
 
The pool of catalysts prepared according to the methodology described in the former 
chapter has been tested in the asymmetric aldol reaction, using the classic addition of 
acetone to p-nitrobenzaldehyde (scheme 25) as a benchmark process to evaluate the 
activity of our peptides. The choice of the right solvent, or solvent mixture, represented a 
challenging factor in the optimization of the reaction conditions and it had a strong 
impact on the yields and selectivities. This may look obvious when dealing with short 
peptides, as changing the reaction environment has a strong impact on the 
intramolecular H-bonds, thus stabilizing a peculiar conformation of the catalyst more than 
another, or rendering it completely unstructured. Moreover, the reaction conditions have 
a strong influence on the kinetics of the reaction and on the evolution of the transition 
state. It will be shown later in this chapter that the addition of water, in particular, had a 
dramatic effect on the outcome of the catalytic process. 
 
 
Scheme 25. Benchmark reaction between acetone and p-nitrobenzaldehyde 
 
 
2.1 Screening of the catalysts in the test aldol reaction 
 
The choice of the solvents used in this first screening process was carried out on the basis 
of their cost, environmental impact, and of the possibility of recovering the catalyst at the 
end of the reaction. DMSO and DMF, the solvents which guarantee the best results in the 
case of proline (for the benchmark reaction a yield of 68% and an ee of 76% are obtained 
in DMSO in 24 hours with 30 mol% proline1a,1b), did not look able to satisfy any of the pre-
requisites above mentioned and were not employed. Wennemers38n and Gong38d have 
shown that short peptides may perform well using acetone directly as a solvent in the 
aldol reaction with 107 and other aldehydes. For this reason we concluded to use acetone 
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in the first test round. The catalyst load was set at 20 mol%, with the intention of 
reducing it progressively in the case of the most active peptides, while a standard 
reaction time of 24 hours was adopted, which, in general, corresponded to the time 
required for a complete, or consistent, conversion of the substrate. L-Proline, was also 
screened in the same conditions, to allow a comparison between its activity and the 
activity of our catalysts. 
 
Table 2. Catalysis results for the test reaction in acetone (20 mol% cat, r.t., 24 h) 
 
 
 
 
 
 
 
 
 
 
               
Although the catalysts were not initially soluble in acetone, the reactions became 
homogeneous (excluding the case of the more polar compounds 91, 92 and 94 having 
two free carboxylic acid functionalities) as the amino functionality of the peptides 
screened formed a more soluble enamine intermediate with acetone. At the end of every 
process the catalysts could be recovered by evaporating the reaction solvent and 
separating it from the organic products through a simple work up procedure followed by 
lyophilization of the subsequent aqueous layers. The preliminary data listed in table 2 
show that some promising candidate catalysts, dipeptide 84, tripeptide 90, and 
tetrapeptides 104 and 101, overcome the selectivity offered by proline in the same 
reaction conditions, and between them, H-Pro-▲-Pro-OH, shows the highest reactivity; it 
entry catalyst yield (%) ee (%) 
1 H-Pro-OH  74 53 (R) 
2 H-Pro-▲-OH (84) 29 64 (R)  
3 H-Pro-▼-OH (89) 56 14 (R)   
4 H-Pro-▲-Pro-OH (90) 99 70 (R) 
5 H-Pro-▲-Asp-OH (91) 55 37 (R) 
6 H-Pro-▲-Glu-OH (92) 30 40 (R) 
7 H-Pro-▼-Pro-OH (93) 80 10 (R) 
8 H-Pro-▼-Asp-OH (94) 45 11 (R) 
9 H-Pro-Pro-▲-OH (95) 65 49 (S) 
10 H-Pro-Pro-▼-OH (88) 98 48 (S)  
11 H-Pro-▼-Pro-Pro-OH (104) 96 58 (S) 
12 H-Pro-▲-Pro-▼-OH (101) 51 70 (R) 
13 H-Pro-▲-Pro-▲-Pro-OH (106) 55 22 (R) 
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also overtakes the conversion rate of proline, and approaches its selectivity in DMSO, 
thus becoming a suitable candidate for further screening and optimization. It is worth 
noting that although the relative ee values leave plenty of room for improvement, some 
catalysts (88, 95, 104) are able to induce the formation of the enantiomer of 60 opposite 
to the one achievable with L-proline or with the other catalysts in our hands, making 
them potentially useful tools, after the necessary optimization of the reaction conditions. 
With this aim, we decided to explore other solvents. For instance, using chloroform as the 
main component of the solvents mixture, instead of neat acetone, we would have limited 
the formation of intermolecular H-bonds between catalyst and solvent, thus favoring the 
stabilization of the secondary structure of the catalysts. At the same time, we wanted to 
check the effect of the addition of water to the organocatalyzed aldol reaction that at 
that time was still unreported, or in a phase of development. For this reason we tried the 
pool of catalysts in two new reaction mixtures, 2:1 chloroform/acetone (table 3) and 5:1 
acetone/water (table 4).     
 
Table 3. Catalysis results for the test reaction in a 2:1 CHCl3/ acetone mixture (20 mol% cat, r.t., 24 h) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
entry catalyst yield (%) ee (%) 
1 H-Pro-OH  68 61 (R) 
2 H-Pro-▲-OH (84) 25 55 (R)  
3 H-Pro-▼-OH (89) 48 10 (R)   
4 H-Pro-▲-Pro-OH (90) 53 29 (R) 
5 H-Pro-▲-Asp-OH (91) 17 0 
6 H-Pro-▲-Glu-OH (92) 18 2 (R) 
7 H-Pro-▼-Pro-OH (93) 61 12 (R) 
8 H-Pro-▼-Asp-OH (94) 10 8 (R) 
9 H-Pro-Pro-▲-OH (95) 59 64 (S) 
10 H-Pro-Pro-▼-OH (88) 79 73 (S)  
11 H-Pro-▼-Pro-Pro-OH (104) 76 33 (S) 
12 H-Pro-▲-Pro-▼-OH (101) 21 71 (R) 
13 H-Pro-▲-Pro-▲-Pro-OH (106) 47 11 (S) 
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Table 4. Catalysis results for the test reaction in a 5:1 acetone/water mixture (20 mol% cat, r.t., 24 h) 
 
 
 
 
 
 
 
 
 
 
 
          
In general, the results listed in table 3, show how that use of the 2:1 CHCl3/acetone 
mixture reduces the reaction rate for each of the catalysts employed and is detrimental to 
the selectivity of most of the catalysts. The catalysis takes place in a homogeneous 
environment after the initial stage required for the formation of the enamine derivatives,  
with the exception of the catalysts bearing two free carboxylic acids (91, 92, 94) which, 
being completely insoluble, show even lower catalytic activity. In contrast to this trend, 
the tripeptides having a β-ACC unit as C-terminal amino acid, enjoy a clear improvement 
of their selectivity, thus proposing H-Pro-Pro-▼-OH (88) as a candidate for further 
optimization.  
The addition of water (table 4) produced a positive effect for some of the catalysts, in 
particular, tripeptides 91 and 92 show a high increase in reactivity and selectivity, while 
the selectivity of 90 increases at expense of a slightly lower activity. In general, a trend 
emerges making the tripeptides which have ▲ as a central building block far more 
selective than their ▼ containing diastereomers. Tetrapeptide 101, shows an interesting 
entry catalyst yield (%) ee (%) 
1 H-Pro-OH  98 0  
2 H-Pro-▲-OH (84) 45 65 (R)  
3 H-Pro-▼-OH (89) 47 0 (R)   
4 H-Pro-▲-Pro-OH (90) 72 74 (R) 
5 H-Pro-▲-Asp-OH (91) 70 62 (R) 
6 H-Pro-▲-Glu-OH (92) 59 73 (R) 
7 H-Pro-▼-Pro-OH (93) 77 6 (R) 
8 H-Pro-▼-Asp-OH (94) 89 13 (R) 
9 H-Pro-Pro-▲-OH (95) 48 0  
10 H-Pro-Pro-▼-OH (88) 83 57 (S)  
11 H-Pro-▼-Pro-Pro-OH (104) 58 0 
12 H-Pro-▲-Pro-▼-OH (101) 36 74 (R) 
13 H-Pro-▲-Pro-▲-Pro-OH (106) 23 35 (R) 
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selectivity and a catalytic performance that is nearly independent of the solvent which is 
used. Unfortunately the yields obtained using this catalyst were always quite low. The 
addition of water appears to be undesirable in the case of the peptides having the β-ACC 
as a C-terminal amino acid. 
In conclusion, two tripeptides, 90 and 88, were able to catalyze the aldol reaction 
between p-nitrobenzaldehyde and acetone in good to high yield and selectivity. The novel 
peptides containing ▲ as a central building block (90, 91, 92) are of particular interest as 
the rigidity of this cyclic amino acid could play an important role in determining their 
good catalytic behavior. A way to estimate this factor is represented by the evaluation of 
the catalytic performance of a peptide such as 97 which contains a β-alanine unit 
replacing ▲ at the center of the amino acid sequence. It can be regarded as the 
conformationally unlocked equivalent of 90 (table 5). 97 did not reach the level of 
selectivity presented by 90 and interestingly, the relative selectivity changes sign by 
switching the reaction condition. This is proof that the peculiar, locked structure of the 
cyclic β-amino acid plays an important role in stabilizing the conformation of 90.    
 
Table 5. Comparison between the organocatalysts 90, 97 and 100 (20 mol% catalyst, r.t., 24 h) 
 
 
 
 
 
 
2.1.1 Optimization of the reaction conditions 
 
The further optimization of the reaction conditions for catalysts 88 and 90 can be carried 
out varying some parameters like the temperature or the composition of the reaction 
mixture which resulted to be suitable for the given peptide. 
 
 
 
 
 
 
 
entry solvent catalyst yield (%) ee (%) 
1 5:1 acetone/water H-Pro-▲-Pro-OH (88) 72 74 (R) 
2 5:1 acetone/water  
H-Pro-β-Ala-Pro-OH (97) 
96 51 (R) 
3 2:1 CHCl3/acetone 66 37 (S) 
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Table 6. Effect of the temperature on the performance of the selected catalysts (20 mol% cat, 24h) 
   
           
The variation of the reaction temperature (table 6) plays an important role in the case of 
tripeptide 88, which shows a remarkable increase in selectivity by switching from room 
temperature to 0°C (entries 4, 5) while a further reduction of the reaction temperature, 
leaves the selectivity unchanged and reduces the yield. This suggests to us that this 
peptide may exist in CHCl3 as a mixture of conformers with the most energetically stable 
conformation being the catalytically active. For this reason, reducing the temperature 
may additionally freeze the structure of the tripeptide thus improving its catalytic 
performance, up to a point where a further decrease of the temperature has only a 
detrimental effect on the yield of the reaction, because no further stabilization is 
achievable. In the case of tripeptide 90, we do not observe any improvement of the 
catalytic behavior by varying the temperature, this may suggest, that the catalytically 
active conformation is not the most energetically stable.  
Another attempt to improve the performance of our catalysts can be carried out by 
changing the composition of the reaction mixtures. In the case of tripeptide 88, we were 
interested in a further reduction of the acetone concentration, while in the case of 90, 
the effect of a change in the number of equivalents of water employed in the reaction 
could be an interesting way to optimize the reaction conditions (table 7). 
 
 
 
 
 
 
 
 
 
 
entry solvent catalyst T yield (%) ee (%) 
1 5:1 acetone/water H-Pro-▲-Pro-OH (90) r.t. 72 74 (R) 
2 5:1 acetone/water H-Pro-▲-Pro-OH (90) 0° C 68 67 (R) 
3 5:1 acetone/water H-Pro-▲-Pro-OH (90) 40° C 70 72 (R) 
4 2:1 CHCl3/acetone H-Pro-Pro-▼-OH (88) r.t. 79 73 (S) 
5 2:1 CHCl3/acetone H-Pro-Pro-▼-OH (88) 0°C 86 88 (S) 
6 2:1 CHCl3/acetone H-Pro-Pro-▼-OH (88) -15 °C 62 88 (S) 
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    Table 7. Effect of water on the test reaction promoted by catalyst 90 (20 mol% cat, r.t.) 
   
            
The reaction tolerates the addition of a large number of equivalents of water, but in 
correspondence to a 1:1 acetone/water composition, the p-nitrobenzaldehyde becomes 
insoluble in the solvent mixture, thus increasing the reaction time and compromising the 
overall catalytic performance. As a consequence, for a higher molar fraction of water 
(entry 7) the reaction is absolutely inhibited. Interestingly, we identified through this 
optimization procedure an ideal acetone/water ratio (entry 2) which will be the one used 
in the further exploration of the scope of our catalyst.  
 
Table 8. Effect of the concentration of acetone on the test reaction promoted by catalyst 
 88 (20 mol% cat, 0°C, 24 h) 
 
 
 
 
          
In the case of catalyst 88, a decrease in the acetone concentration (table 8) did not 
produce a positive effect and tends to be unfavorable for the yield of the process.  
As a last step towards the optimization of the process, the possibility to reduce the 
catalysts load was examined. Considering that the preparation of the β-ACCs containing 
entry solvent water/acetone 
(equiv./equiv.) 
time (h) yield (%) ee (%) 
1 acetone 0/130 24 99 70 (R) 
2 10:1 acetone/water 50/120 24 89 78 (R) 
3 5:1 acetone/water 90/110 24 72 74 (R) 
4 3:1  acetone/water 140/100 24 96 71 (R) 
5 2:1  acetone/water 190/90 24 71 68 (R) 
6 1:1  acetone/water   280/70 48 53 61 (R) 
7 1:2 acetone/water 460/20 48 - - 
entry solvent equiv. of acetone yield (%) ee (%) 
1 2:1 CHCl3/acetone 45 86 88 (S) 
2 3:1 CHCl3/acetone 35 83 88 (S) 
3 10:1 CHCl3/acetone 10 56 86 (S) 
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peptides is relatively challenging and that they are much more expensive than proline, a 
reduction in the amount of catalyst required for an efficient and selective conversion of 
the substrate, represents a very important goal. The experimental results (table 9) show 
that the load of the catalysts 88 and 90 can be reduced to 5 and 10 mol% respectively, 
with small losses in the yields and selectivities. 
 
 
Table 9. Effect of the catalyst load on the test reaction promoted by catalyst 88 and 90 (24 h) 
 
 
 
2.1.2 Scope of the catalysts 
 
The selected catalysts were screened in the aldol reaction between acetone and aromatic 
or aliphatic aldehydes, using the optimized reaction conditions (scheme 26, tables 8 and 
9). The results obtained in the case of tripeptide 88, are compared with the results 
obtained for proline in the same reaction conditions. The same comparison has not been 
reported for catalyst 90, as it was observed during the first screening round (table 4, entry 
1) that proline provided only racemic products, in this reaction, in the presence of water. 
In the case of tripeptide 88, the reaction temperature has been adjusted for each 
substrate at the optimal value needed to reach a compromise between reactivity and 
enantioselectivity (table 10). 
 
 
Scheme 26. Organocatalyzed aldol reaction between various aldehydes and acetone 
entry catalyst solvent T catalyst load 
(mol %) 
yield 
(%) 
ee 
(%) 
1  
 
90 
 
 
10:1 acetone/water 
 
 
r. t. 
20 89 78 (R) 
2 10 74 73 (R)  
3 5 9 71 (R)  
4    20 86 88 (S) 
5 88 2:1 CHCl3/acetone 0°C 10 80 88 (S) 
6    5 75 83 (S) 
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Table 10. Catalyst 88 and proline in the reaction of scheme 27 (20 mol% cat, 24h, 2:1 CHCl3/acetone)    
           
The experimental results prove that 88 can promote the aldol reaction with moderate to 
high yields and with a high enantioselectivity. In general, it performs remarkably better 
than proline for what concerns the aromatic aldehydes, either in the same reaction 
conditions, or in DMSO2. Proline, instead, confirms to be an excellent catalyst in the case 
of the aliphatic substrates. 
 
 
 
 
 
 
entry catalyst R T yield 
(%) 
ee (%) 
 
1 
H-Pro-Pro-▼-OH (88)  
Ph (52) 
10°C 50 79 (S) 
H-Pro-OH r.t. 28 42 (R) 
 
2 
H-Pro-Pro-▼-OH (88)  
p-Cl-Ph (108) 
10°C 42 84 (S) 
H-Pro-OH r.t. 37 50 (R) 
 
3 
H-Pro-Pro-▼-OH (88)  
o-Cl-Ph (109) 
5°C 70 80 (S) 
H-Pro-OH r.t. 87 64 (R) 
 
4 
H-Pro-Pro-▼-OH (88)  
o-Br-Ph (110) 
5°C 84 82 (S) 
H-Pro-OH r.t. 88 65 (R) 
 
5 
H-Pro-Pro-▼-OH (88)  
p-NO2-Ph (60) 
0°C 86 88 (S) 
H-Pro-OH r.t. 68 61 (R)  
 
6 
H-Pro-Pro-▼-OH (88)  
p-CF3-Ph (111) 
0°C 82 87 (S) 
H-Pro-OH r.t. 65 63 (R)   
 
7 
H-Pro-Pro-▼-OH (88)  
o-NO2-Ph (112) 
r.t. 88 88 (S) 
H-Pro-OH r.t. 58 92 (R)    
 
8 
H-Pro-Pro-▼-OH (88)  
c-C6H11 (113) 
r.t. 57 82 (S) 
H-Pro-OH r.t. 55 94 (R) 
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Table 11. Catalyst 90 in the reaction of scheme 27 (20 mol% cat, 24h, 10:1 acetone/water, r.t.) 
 
 
 
 
 
 
 
 
         
Tripeptide 90, proved to be a good catalyst for the aldol reaction between acetone and 
aromatic aldehydes, with low to moderate yields in the case of the deactivated substrates 
and very good yields in the case of more reactive aldehydes. The enantioselectivity is 
generally good to high, slightly lower than what is observed in the case of 88, but still 
generally improving the performance of proline in DMSO or in the CHCl3/acetone mixture. 
Unfortunately 90 did not perform well in the case of the aliphatic aldehydes. 
In conclusion, 88 and 90 are efficient catalysts for the aldol reaction, promoting the 
formation of the aldol products with opposite enantioselectivity. Compared to proline, 
the increased selectivity of these catalysts is a good tradeoff for an improved catalytic 
performance in low boiling solvent mixtures (88) or in the presence of water (90) which 
allowed the recovery of the catalysts through an aqueous work up. A comparison with the 
literature results may be carried out by considering Wennemers´ tripeptides38n (66 and 
115), the first catalytically active tripeptides reported, and Gong´s dipeptide38d (67), 
clearly the best catalyst for the aldol reactions of acetone (scheme 27, table 11). By 
comparing the results obtained in the case of some standard substrates (reaction in 
scheme 27), we are able to see that peptides 88 and 90 reach and generally overcome the 
level of selectivity, although not the reactivity, of catalysts 66 and 115, either in the 
formation of the S or the R enantiomer. Catalyst 67, instead, is unrivaled for selectivity 
entry R yield (%) ee (%) 
1 Ph (60) 48 76 (R) 
2 p-Cl-Ph (108) 43 80 (R) 
3 p-NO2-Ph (60) 89 78 (R) 
4 p-CF3-Ph (111) 80 80 (R) 
5 p-F-Ph (114) 13 72 (R) 
6 o-Br-Ph (110) 86 72 (R) 
7 o-Cl-Ph (109) 80 68 (R) 
8 o-NO2-Ph (112) 82 91 (S) 
9 c-C6H11 (113) 57 41 (R) 
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and reactivity, although it requires low reaction temperatures and can promote only the 
formation of the R enantiomer. 
 
Scheme 27. Wennemers´ (66, 115) and Gong´s (67) catalysts for the aldol reaction 
 
 
 
Table 12.  Tripeptides 90 and 88 compared with the catalysts 66, 115 and 67 as reported in literature for 
   the organocatalyzed aldol reaction (Scheme 27, 24h) 
 
a
Taken for refererence 38n. 
b
Taken from reference 38d 
 
 
 
entry catalyst R catalyst load 
(mol %) 
T yield 
(%) 
ee 
(%) 
1 H-Pro-Pro-▼-OH (88)  
 
 
p-NO2-Ph 
20 0°C 86 88 (S) 
2 H-Pro-▲-Pro-OH (90) 20 r.t. 89 78 (R) 
3 66a 1 r.t. 99 80 (S) 
4 115a 10 r.t. 73 70 (R) 
5 67b 2 -25°C 62 99 (R) 
6 H-Pro-Pro-▼-OH (88)  
 
 
 
Ph 
20 10°C 50 79 (S) 
7 H-Pro-▲-Pro-OH (90) 20 r.t. 48 76 (R) 
8 66a 1 r.t. 69 78 (S) 
9 115a 10 r.t. 58 66 (S) 
10 67b 2 -25°C 68 98 (R)  
11 H-Pro-Pro-▼-OH (88)  
 
 
c-C6H11 
20 r.t. 57 82 (S) 
12 H-Pro-▲-Pro-OH (90) 20 r.t. 57 41 (R)   
13 66a 1 r.t. 66 82 (S) 
14 115a 10 r.t. 56 83 (R)    
15 67b 5 -25°C 80 99 (R) 
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2.2 Organocatalyzed aldol reaction between cyclic ketones and aldehydes 
 
In the case of more complex ketones, we observe some remarkable differences in 
comparison to the aldol reaction of acetone. In general, these substrates are only partially 
miscible with water, thus introducing the possibility of carrying out the process in biphasic 
water-ketone mixtures. Moreover, the increased complexity of the ketone makes it more 
expensive and less indicated to be used as a solvent or a co-solvent of the reaction, 
requiring, in this way, the development of new catalytic systems in which it is used in 
almost equivalent amounts. Among such ketones, cyclic ketones have been attracting a 
large interest57 in recent years, with the organocatalyzed aldol reactions of 
cyclohexanone or cyclopentanone being regarded as useful benchmarks for the 
development of new catalysts (scheme 28). 
 
 
Scheme 28. The standard, organocatalyzed aldol reaction between cyclic ketones and aldehydes 
 
It is important to notice that while the use of proline in this reaction is restricted to the 
case of aliphatic aldehydes (scheme 11), other acyclic amino acids, such as alanine or 
valine57e,57f, proved to be extremely selective for a wider range of substrates. Although 
the solvent used consisted basically of wet DMSO and the reaction times were quite long 
(3-4 days), this discovery highlighted the potentiality of water to positively influence the 
organocatalyzed aldol reaction, prompting many research groups to develop catalysts 
able to promote this reaction in an aqueous medium, that can be seen as an inexpensive, 
environmentally friendly alternative to the organic solvents. As the solubility of most 
cyclic ketones in water is generally low, the reaction has to be run in biphasic 
water/ketones systems or in heterogeneous mixtures consisting of a suspension or 
emulsion of the reagents in water. This experimental observation led to an interesting 
debate on whether the catalytic process would take place effectively in water, at the 
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interface, in the organic layer or in a “concentrated organic phase”. Hayashi58 and 
Barbas
57e were the first to report the development of catalysts able to efficiently perform 
the aldol reaction (scheme 28) “in water” (water/cyclohexanone 10:1 (v/v)). Dickerson 
and Janda59 argued that the water insoluble ketone would have acted, in this case, as the 
real solvent for the catalytic process, sequestrating the organic material, together with 
the enamine intermediate, in hydrophobic pockets which would have excluded the bulk 
water from the reaction, thus making the term “in water” misleading. This idea can 
explain why the catalysts that present a faster aldol substrate conversion rate in aqueous 
media, contain a hydrophobic side-chain able to trigger the inclusion of their enamine 
derivative in the organic layer (scheme 29) and has been recently supported by 
Armstrong
57d and by Gryko57c who conjugated the use of an organocatalyst in the 
presence of water with the addition of β-cyclodextrin or NaCl. Such additives are able to 
exalt the formation of concentrated hydrophobic droplets in which the organic reagents 
come in close contact and are able to react. For the reasons above mentioned, we will 
refer to this class of transformations as reactions “in the presence of water”57a,60 rather 
than as reactions “in water” although water represents the main component of the 
system. It is interesting to add in this context that it is still not clear why the reaction in 
the concentrated organic phase that forms in presence of water enjoys experimentally a 
higher level of enantioselectivity than the same process in a homogeneous, water free 
environment57,69. This may require a further explanation of the role of the water 
molecules at the interface with the organic phase in coordinating the transition state of 
the reaction.            
 
    
Scheme 29. Barbas´ (29), Hayashi´s (61) and Gryko´s (117) effective organocatalysts for the aldol reaction of cyclic 
ketones in presence of water 
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2.2.1  β-ACC containing tripeptides as catalysts for the aldol reaction of cyclic 
ketones 
 
In the search for efficient and versatile organocatalysts we were interested in proving 
that tripeptides 88 and 90 may serve well in the aldol reaction between cyclic ketones 
and aldehydes. For this reason, they were tested for the standard reaction in scheme 30 
in the conditions that proved to be effective in the case of acetone. As catalyst 90 had 
proved to be effective in acetone/water mixtures, a 20:1 and a 10:1 cyclohexanone/water 
mixture were used in the screening process. In the first case, the reduced amount of 
water allows its dissolution in cyclohexanone, thus making the system monophasic and 
the subsequent aldol reaction homogeneous. In the latter case a dispersion of small 
water droplets in cyclohexanone was observed, leading to a biphasic, heterogeneous 
reaction mixture. In both cases, the aldehyde substrate and the catalysts were completely 
dissolved in one of the mixture components. In the case of catalyst 88, which had proved 
to be extremely effective in a CHCl3/ketone mixture, both CHCl3/cyclohexanone and 
cyclohexanone/water mixtures were tested. Although it is clearly not convenient from an 
economical and environmental point of view, we tested the reaction in the neat ketone 
as well, to better clarify the effect of the addition of water.  
 
 
Scheme 30. Benchmark organocatalyzed aldol reaction between p-nitrobenzaldehyde and cyclohexanone 
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Table 13. Catalysts screening for the aldol reaction in scheme 30 
 
 
Proline is not a good catalyst for the aldol reaction between cyclic ketones and aromatic 
aldehydes2b, either in DMSO (see scheme 11) or in cyclohexanone/water mixtures (entry 
1, table 13). Tripeptide 88 does not perform efficiently for this process (entries 6 to 8, 
table 13) either. Catalyst 90, instead, proved to have an interesting activity in the test 
reaction, in particular, in the heterogeneous ketone/water mixture (although only in the 
presence of a high excess of ketone (entry 5). In this condition, we observed a higher 
enantio- and diastereoselectivity than in the homogeneous mixture, although at the 
expense of a reduced reaction rate.  
Encouraged by this result, catalyst 90 was screened in the aldol reaction between 
aromatic aldehydes and cyclic ketones, either in the heterogeneous or in the 
homogeneous reaction conditions (scheme 31, tables 14 and 15). 
entry catalyst solvent mixture 
(v/v) 
cyclohexanone/
water 
equiv.:equiv. 
Time 
(h) 
yield 
(%) 
ee 
anti  
(%) 
ee 
syn 
(%) 
dr  
(anti/syn) 
 
1 
 
H-Pro-OH 
20:1 
cyclohexanone/
water 
 
25:5 
 
24 
 
66 
 
88 
 
52 
 
2:1 
2 H-Pro-▲-Pro-OH cyclohexanone 25:0 24 76 66 10 3:1 
 
3 
 
H-Pro-▲-Pro-OH 
20:1 
cyclohexanone/
water 
 
25:5 
 
24 
 
96 
 
87 
 
73 
 
2:1 
 
4 
 
H-Pro-▲-Pro-OH 
10:1 
cyclohexanone/
water 
 
25:10 
 
48 
 
75 
 
95 
 
99 
 
6:1 
 
5 
 
H-Pro-▲-Pro-OH 
1:10 
cyclohexanone/
water 
 
5:150 
 
48 
 
- 
 
- 
 
- 
 
- 
6 H-Pro-Pro-▼-OH cyclohexanone 25:0 24 98 8 2 1:1 
 
7 
 
H-Pro-Pro-▼-OH 
2:1 
CHCl3/cyclohexa
-none 
 
30:0 
 
24 
 
95 
 
0 
 
0 
 
1:1 
 
8 
 
H-Pro-Pro-▼-OH 
20:1  
cyclohexanone/
water 
 
25:5 
 
24 
 
97 
 
17 
 
11 
 
1:1 
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Scheme 31. The aldol reaction between cyclohexanone (27), cyclopentanone (116) or tetrahydropyran-4-one (118) and 
aromatic aldehydes, catalyzed by 90 
 
 
Table 14.  Catalyst 90 in the homogenous aldol reaction between cyclic ketones and aromatic aldehydes 
(24 h, r.t.) 
 
 
 
 
 
entry R1  R ketone/water 
(v/v) 
catalyst 
load 
(mol %) 
yield 
(%) 
ee 
anti  
(%) 
ee 
syn 
(%) 
dr 
(anti/syn) 
1 p-NO2 (61)  
 
 
-(CH2)3- 
20/1 20 96 87 73 2:1 
2 p-Cl (119) 20/1 20 50 91 66 9:1 
3 o- NO2 (120) 20/1 20 69 80 - >60:1 
4 o-Cl (121) 20/1 20 63 90 - 45:1 
5 o-Br (122) 20/1 20 72 93 - 40:1 
6 p-NO2 (123)  
 
 
-CH2OCH2- 
20/1 20 71 83 87 1:2 
7 p-NO2 (123) 3/1 20 80 91 76 3:2 
8 o-Br (124) 20/1 20 35 83 53 1:1 
9 o-Br (124) 3/1 20 70 83 85 3:1 
10 o- NO2 (125) 3/1 20 79 86 - 4:1 
11 p-NO2 (126)  
-(CH2)2- 
20/1 10 99 56 49 3:1 
12 p-NO2 (126) 10/1 10 90 61 37 3:1 
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Table 15.   Catalyst 90 in the heterogeneous aldol reaction between cyclic ketones and aromatic aldehydes  
 (48 h, r.t.) 
 
 
The use of catalyst 90 allows the preparation of the aldol product between 
cyclohexanone and aromatic aldehydes in good yields and with high enantio- and 
diastereoselectivity (entries 1-5, table 14), which becomes excellent in the case of the 
heterogeneous reaction conditions (entries 1-5 table 15). This notwithstanding, a 
remarkable decrease of the overall substrate conversion rate in the biphasic system was 
observed, which brings the suppression of the reaction between deactivated aldehydes 
like p-chlorobenzaldehyde and cyclohexanone (entry 3, table 15). This effect is probably 
due to the high water solubility of 90, which gets trapped in the aqueous layer and is 
therefore less available for the catalytic process. In the case of the tetrahydropiran-4-one 
118, a ketone which is miscible with water in every proportion, we obtained generally a 
high enantioselectivity either in the case of the anti or of the syn isomer (entries 6-10, 
table 14), although we were are not able to achieve a good diastereomeric control. This 
reaction shows to be influenced by the amount of water added as we switched from a 
20:1 to a 3:1 ketone/water mixture, with the latter granting the best diastereo- and 
enantioselectivity. Cyclopentanone (116) proved to be a very challenging substrate; 
although its high reactivity allowed the reduction of the catalytic load to only 10 mol%, 
only moderate enantioselectivity and a low syn diastereoselectivity were achieved. 
 
 
entry R1 R ketone/water 
(v/v) 
catalyst 
load 
(mol %) 
yield 
(%) 
ee 
anti  
(%) 
ee 
syn 
(%) 
dr 
(anti/syn) 
1 p-NO2 (61)  
 
 
-(CH2)3- 
10/1 20 75 95 99 6:1 
2 p-Cl (119)  10/1 20 - - - - 
3 o-NO2 (120)  10/1 20 50 98 - 30:1 
4 o-Cl (121) 10/1 20 40 98  70:1 
5 o-Br (122)  10/1 20 60 95  90:1 
6 p-NO2 (126) -(CH2)2- 5/1 10 70 68 40 1:2 
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2.3 Intramolecular aldol reactions 
 
The intramolecular aldol reaction represented the first organocatalytic approach to the 
aldol reaction (scheme 2)4,5 and, in general, the first highly enantioselective example of 
organocatalysis. Usually, the ring closure reactions in scheme 32 represent the most 
extensively studied processes for this family of transformations and can be classified as 
“enolendo” or “enolexo” reactions, accordingly to the destiny of the ketone functionality 
which acts as the aldol donor, to be included in the newly formed ring or to be left 
outside of it.       
 
 
 
 
Scheme 32. Classic examples for the organocatalyzed “enolendo” (above) and “enolexo” (below) intramolecular aldol 
reaction 
 
In the seventies, Hajos, Parrish, Eder, Sauer and Weichert4,5 showed that only 3 mol% of 
proline in DMF could afford the intermediate alcohol 4, in 20 hours, in quantitative yield 
and with an ee of 93%; successive dehydration of this intermediate using p-TsOH would 
provide 5. The intramolecular aldol reaction of triketone 55 proved to be, instead, much 
more challenging. Barbas35 showed that using 30 mol% of proline in DMSO, a yield of 49% 
and a selectivity of 76% could be obtained in 90 hours directly from methylvinyl ketone 
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and 2-methyl-1,3-cyclohexanedione, through a Michael addition-aldol reaction one-pot 
cascade. Recrystallization of 56 would provide this product in its enantiomerically pure 
form. The use of antibodies61 was reported for the enantioselective synthesis of 56. More 
recently, it was shown that the unnatural amino acid cispentacine62 (130, scheme 33) is 
able to catalyze the formation of 127 in DMF, whose subsequent dehydration furnished 
56 in quantitative yield and with an ee of 86%. Bismorpholine catalyst 131, has also been 
reported63 as an extremely selective catalyst for this reaction.  
 
 
Scheme 33. cispentacine 130 and bismorpholine 131 are effective catalysts for the intramolecular aldol reaction  
 
This notwithstanding, it would be useful to develop a catalyst for this process able to 
promote it as a one-pot reaction at room temperature; moreover, the use of a low boiling 
solvent would allow to avoid the complicated work up necessary to extract the products 
from solvents like DMF or DMSO and enhance the possibility of recovering the catalyst. A 
lower catalyst load and a reduced reaction time, in comparison to the catalysts previously 
described, are desirable as well. For these reasons, peptides 88, 90, 93, 101 and 104 were 
tested in this reaction, using chloroform as solvent and only 10 mol% of catalyst (table 
16).  
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 Table 16.  Catalysts screening for the intramolecular aldol reaction of triketone 55  
   in CHCl3, r.t., 24 h, 10 mol% catalyst) 
 
 
                                        
 
 
 
 
                                 a isolated yield, b estimated conversion through chiral GC. 
 
Interestingly, tripeptide 90 (entry 2, table 16) proved to be once again the most active 
and selective catalyst in our hands, promoting this reaction with a selectivity superior to 
any other peptide tested or to proline, either in DMSO or in the same conditions. It 
approaches the selectivity observed in the case of the bismorpholine catalyst 131, but in 
only 24 hours and at room temperature. This result encouraged us to extend the study of 
the catalytic behavior of 90 to the intramolecular aldol reaction of other triketones 
(scheme 34) and to explore different reaction conditions (table 17). 
 
 
 
Scheme 34. Other interesting intramolecular aldol reactions. 
 
 
 
 
 
entry catalyst yield (%) ee  
(%) 
1 H-Pro-OH  27b 57 
2 H-Pro-▲-Pro-OH (90)  88a 92 
3 H-Pro-▼-Pro-OH (93)  11b 37 
4 H-Pro-Pro-▼-OH (88)  10b 38 
5 H-Pro-▼-Pro-Pro-OH (101)  31b 61 
6 H-Pro-▲-Pro-▼-OH (104) traces n.d. 
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Table 17. Results for the intramolecular aldol reaction promoted by 90 (r.t., 24-48h, 10 mol% catalyst) 
      a20 mol% of catalyst were employed 
 
The intramolecular aldol reaction of 3 to provide compound 5 in CHCl3 requires a far 
longer reaction time than its 6-member ring analogue 55 (entries 1-2, table 17). Five days 
are required for a complete conversion of the starting material to the cyclized product 
and although 90 can guarantee quite a higher selectivity than proline in the same reaction 
conditions, its performance is not comparable to what is observed using 3 mol% of 
proline in DMF4,5 (complete conversion of 3 in 20 hours; 93% ee after the dehydration of 
4). An attempt to use 90 in more polar solvents resulted in the complete inhibition of the 
excellent catalytic activity observed in the case of 55 (entries 3-5), a sign that the peculiar 
structure of this catalyst is disrupted in such environment. The use of a mixture of water 
and organic solvents (in this case THF) which proved to be helpful in the case of the 
intermolecular aldol reaction, only had the effect to reduce the activity of the catalyst 
(entry 6). Finally we tried tripeptide 90 and proline in the annulations of 132 and 134; 
while the first of them is reported to undergo the selective intramolecular aldol reaction 
using as much as one equivalent of phenylalanine in harsh reaction conditions64, the 
second cyclization is still unreported. Unfortunately either proline or 90 failed in providing 
the desired products in CHCl3 and in DMSO. 
entry catalyst triketone solvent time 
(d) 
yield 
(%) 
ee  
(%) 
1 H-Pro-OHa  
3 
CHCl3 5  99
 22 
2 H-Pro-▲-Pro-OH CHCl3 5  95
 83 
3 H-Pro-▲-Pro-OH  
 
 
55 
DMSO 2  - - 
4 H-Pro-▲-Pro-OH DMF 2  - - 
5 H-Pro-▲-Pro-OH MeCN 2  traces n.d. 
6 H-Pro-▲-Pro-OH 10:1 THF/H2O 1 49 92 
7 H-Pro-OHa  
132 
DMSO 2 - - 
8 H-Pro-▲-Pro-OHa CHCl3 2 - - 
9 H-Pro-OHa  
134 
DMSO 2 - - 
10 H-Pro-▲-Pro-OHa CHCl3 2 - - 
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2.3.1 “Enolendo” intramolecular aldol reaction 
 
The organocatalytic “enolendo” cyclizations were reported by List34. Proline (scheme 35) 
resulted to be an effective catalyst in the case of the heptanediale 38, but was less 
suitable for the enantioselective synthesis of 129.   
 
 
Scheme 35. The enolendo intramolecular aldol reaction catalyzed by proline 
 
The peptides in our hands (fig. 9 and scheme 24) were tested as organocatalysts in the 
intramolecular aldol reaction of 128, as no organocatalyst has been reported to 
effectively promote this process. To prepare compound 128 we carried out an oxidative 
ring opening of trans-1,2-cyclohexanediol with H2O/SiO2/NaIO4, while 129 was 
immediately treated with NaBH4 in EtOH, as it undergoes complete dehydration within a 
few hours, with the consequent loss of the chiral information (scheme 36). In this way, 
this process can be regarded as the synthesis of diol 137 starting from diol 136. 
Interestingly, 5 mol% of any of the peptides tested can catalyze the fast and complete 
cyclization of 128, but generally, with low enantio- and diastereoselectivity. Dipeptide 84 
(entry 2, table 18) is the only one able to provide an enantioselectivity superior to the one 
obtained with proline in the same reaction conditions, but with almost no anti/syn 
selectivity. Tetrapeptide 104 (entry 6, table 18) promotes the conversion of the starting 
material in only 5 min and with good diastereoselectivity obtaining racemic 137 in its 
trans-isomer. A slightly higher diastereoselectivity (9:1 anti/syn) has been obtained only 
by Lee65 using a HgCl2 catalyzed reduction of 2-hydroxymethylcyclopentanone in 12 hours 
in the presence of 10 equivalents of Mg. Pentapeptide 106 and tripeptide 88 were able 
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tead to promote the formation of an excess of the syn-isomer of 129, although with low 
or no chiral induction.      
 
 
Scheme 36. Synthesis the diol 137 as final product of the organocatalytic ring closure of 128 
 
Table 18. Results for the peptide catalyzed intramolecular aldol reaction of 128 (CHCl3, at r.t., with 5 mol% 
of catalyst, conversion of the starting material was always complete) 
       a10 mol% of proline were employed 
 
 
2. 4 Other Reactions 
 
In the search for efficient and versatile organocatalysts, it was of our interest to explore 
the behavior of the peptides synthesized, in other common C-C bond forming reactions. 
entry catalyst conversion 
time (min) 
ee anti   
(%) 
ee syn 
(%) 
dr 
anti/syn 
1 H-Pro-OHa 30 54 - 2:1 
2 H-Pro-▲-OH (84) 15 71 - 3:2 
3 H-Pro-▼-OH (89) 15 39 - 3:2 
4 H-Pro-▲-Pro-OH (90) 15 6 - 3:2 
5 H-Pro-Pro-▼-OH (88) 15 5 - 1:2 
6 H-Pro-▼-Pro-Pro-OH (104) 5 - - 7:1 
7 H-Pro-▲-Pro-▼-OH (101) 15 - - 1:1 
8 H-Pro-▲-Pro- Pro-▲-OH (106) 15 26 - 1:2 
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In particular, other processes able to proceed through the formation of an enamine 
intermediate can represent useful benchmarks in this case. 
 
2.4.1 Mannich Reaction 
 
The three component Mannich reaction (scheme 37) was regarded as a possible 
candidate to expand the field of application of peptides 88 and 90. List1a,66 reported that 
35 mol% of proline, in DMSO, are able to catalyze this process with excellent 
enantioselectivity, although only moderate yields were reported, due to the concurrent 
formation of the aldol product 60 between acetone and the aldehyde substrate. As 
previously reported, DMSO was not regarded by us as a convenient solvent and the 
Mannich reaction was carried out directly in acetone, or in a CHCl3/acetone using 
catalysts 88 and 90 (20 mol%). To our great disappointment, although traces of the 
Mannich product were observed, the aldol product resulted to be by far the main product 
of the process, independent of the reaction conditions or of the kind of aldehyde 
employed.         
 
Scheme 37. The organocatalyzed three component Mannich reaction (above) and the related two component process 
involving the preformed imine (below) 
 
Switching from the classic Mannich reaction to the addition of acetone to the preformed 
imine 139, was regarded as a way to avoid the formation of the undesired aldol product. 
Unfortunately, no formation of the Mannich product was observed under these 
conditions and, over time, the decomposition of 139 brought again the formation of the 
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aldol product. An analogous reaction (scheme 38), involves the addition of acetone to the 
preformed imine between ethyl glyoxylate and an aromatic amine67. 
 
     
Scheme 38. The reaction between acetone, ethyl glyoxylate and p-methoxyaniline, proceeding through the preformed 
imine 141 
 
This process did provide only traces of racemic 142, either using catalyst 88 or 90. We 
concluded that these peptides are not suitable catalysts for the Mannich reaction. 
 
2.4.2 Michael addition 
 
Michael addition represents another important C-C bond forming reaction. The process in 
scheme 39 has been reported by Barbas68 and was used as a benchmark reaction. While 
proline did not show to be an active catalyst for this process, diamine 143 showed a 
promising activity68. Similarly to proline, the peptides synthesized (Fig. 9 and scheme 24) 
did not prove to be able to promote this reaction, unless a catalytic amount of a base is 
added to deprotonate them at the carboxylic functionality. Triethylamine, which is not an 
active catalyst for this process (table 19, entry 13) was employed, and the reactions were 
carried out in neat acetone. 
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Scheme 39. Organocatalyzed Michael addition between acetone and 144 (above) and Barbas´ diamine catalyst 143 
(below) 
 
Table 19.  Catalysts screening for the Michael addition (in acetone, at r.t., 24 h, 20 mol% catalyst + 20 mol% 
TEA) 
 
 
 
 
 
 
                                        
 
 
 
                    
                a On the base of the value reported by Barbas68 (αD = 10.2 for 145 (61% ee)) 
 
entry catalyst yield (%) αD  
(CHCl3) 
calculated 
ee
a
 (%) 
1 H-Pro-OH - - - 
2 H-Pro-OH/TEA 62 +1.0 6 
3 H-Pro-▲-OH/TEA 25 0 0 
4 H-Pro-▼-OH/TEA 55 0 0 
5 H-Pro-▲-Asp-OH/TEA 45 -1.0 6 
6 H-Pro-▼-Asp-OH/TEA 46 0 0 
7 H-Pro-▲-Glu-OH/TEA 50 +6.1 36 
8 H-Pro-▲-Pro-OH/TEA 37 0 0 
9 H-Pro-▼-Pro-OH/TEA 56 0 0 
10 H-Pro-Pro-▼-OH/TEA 60 +2.7 17 
11 H-Pro-▼-Pro-Pro-OH/TEA 65 0 0 
12 H-Pro-▲-Pro-▼-OH/TEA 33 -1.2 7 
13 TEA traces n.d. - 
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Unfortunately, although in comparison with catalysts 143 some of the peptides employed 
in the screening process could provide moderate yields in only 24 hours (entries, 4, 9, 7, 
11) the enantioselectivity observed for this reaction was generally very low.  
In conclusion, the screening process of our peptides in the aldol reaction between 
acetone and p-nitrobenzaldehyde (scheme 25) and the further optimization procedure, 
allowed us to identify two efficient catalysts, H-Pro-▲-Pro-OH (90) and H-Pro-Pro-▼-OH 
(88) able to promote the aldol reaction between different aldehydes and acetone in high 
yields and selectivity. Catalyst 90 showed later to be the most versatile between the 
peptides synthesized, performing well in the aldol reaction between cyclic ketones and 
aromatic aldehydes and in the intramolecular aldol reaction; this notwithstanding, some 
issues connected to its catalytic activity, like the large excess of ketone required and the 
slow conversion rate in the heterogeneous aldol reaction, can be addressed only by 
modifying the structure of our catalyst and will be examined in the next chapter.  
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Chapter 3: Development and applications of new catalysts 
 
3.1 Development of new catalysts 
 
In the previous chapter we showed that the unnatural β-amino acids ▲, (+)-69, and ▼,   
(-)-69, can be used as useful building blocks for the synthesis of “reasonable” and 
sometimes excellent catalysts like 90 and 88. Naturally the results obtained leave plenty 
of room for improvement. In particular, 90 represents in our opinion a very interesting 
molecule from a structural point of view (see chapter 4) and is quite versatile, performing 
extremely well in the intramolecular aldol reaction and providing excellent selectivities in 
the heterogeneous reaction between cyclohexanone and aromatic aldehydes. In this case 
it would be useful to compare the catalytic activity of 90 with some interesting examples 
reported in literature during the last few years57,69 (fig. 10). 
 
 
Fig. 10. Catalysts comparison for the aldol reaction between cyclohexanone and aromatic aldehydes in aqueous media   
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While the selectivities and the reaction times observed for 90 are comparable to the case 
of the excellent catalysts reported above, some other parameters are for sure 
unsatisfactory. Although the procedure that enables us to quantitatively recover 90 at the 
end of the process may upset the high catalytic load required, more remarkable is the fact 
that a very high excess of ketone is needed for an efficient conversion of the substrates, 
and this notwithstanding, deactivated aldehydes do not react at all (in heterogeneous 
conditions) in the presence of 90 (see table 15). 
A plausible explanation for this drawback may be found analyzing the structures reported 
in fig. 10; it is easy to notice that only 90 misses a lipophilic side chain which would favor 
its inclusion in the organic phase of the heterogeneous aldol reaction. For this reason, 
while the other catalysts are able to interact with the organic material suspended in 
water, 90 ends up to be sequestrated in the aqueous phase of the reaction. Under such 
conditions, we can achieve good reactivity only adding large amounts of ketone and using 
more reactive aldehydes. 
A similar observation has been reported by Gong57b who reported that catalyst 67 
performs outstandingly in the homogeneous aldol reaction between acetone and 
aldehydes38c, but it is less suitable for heterogeneous processes. This behavior was 
similarly explained on the base of its increased hydrophilicity. Its analog 146, that is 
basically the same catalyst with an “apolar arm”, is a extraordinary catalyst for the aldol 
reaction of cyclohexanone in the presence of water. 
In the search for an improved catalytic system, we did not believe that the use of 
addictives, like in the case of 11757c or 14757d, would have led to any particular 
improvement. The latter catalysts are already able to work in absence of a high excess of 
ketone and the addition of a “salting-in” compound has the only effect of improving the 
aggregation of the organic material in concentrated droplets, thus accelerating the 
reaction. The ability of the catalyst to pass into the organic phase after the formation of 
the enamine intermediate is still required. Moreover, such hydrosoluble addictives would 
have made the recovery of the pure tripeptide impractical, thus being unsuitable for a 
catalyst which requires a high load. 
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For these reasons, we concluded that the most practical way to improve our catalyst 
would be “attaching” a hydrophobic side chain to 90; this could be carried out by 
substituting the N-terminal proline with a suitably alkylated trans-hydroxyproline. We 
desired to keep the molecular weight of the resulting catalyst as low as possible and we 
needed at the same time to introduce a group which would have been stable under the 
protection-deprotection conditions used during the synthesis of our peptides; for this 
reason, we excluded from the pool of the available side-chains the bulky silylated 
substituents used by Hayashi57a (61) and Gong57b (146) or long alkyl chains (see catalyst 
29)57e and settled on a simple benzyl group (scheme 41). To have a more comprehensive 
overview of the role of this substituent a preliminary screening to evaluate the catalytic 
properties of the benzylated trans-hydroxyproline H-Hyp(OBn)-OH (148) was carried out 
in comparison with proline and with the proline-based catalysts 61, in the same 
conditions used by Hayashi57a (table 20, scheme 40).  
 
 
Scheme 40. The organocatalyzed aldol reaction between 27 and 107 in presence of water and of 5 equiv. of ketone 
 
Table 20. Preliminary screening of catalyst 148 for the aldol reaction in scheme 40 and its comparison with 
analogous catalysts (10 mol% cat., r.t., 5 equiv. of 27 in presence of water, 16-18 equiv.) 
 
     
 
 
            aTaken from reference 57a 
 
entry catalyst time (h) yield (%) dr 
(anti/syn) 
ee anti 
(%) 
1 H-Pro-OH 24 traces - - 
2 H-Hyp(OBn)-OHa 12 85 1:1 ≈0 
3 H-Hyp(OTBDPS)-OH 5 86 20:1 >99 
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As expected (entry 1), a small, highly water soluble molecule like proline is not able to 
catalyze the heterogeneous aldol reaction in presence of a large excess of water; this 
notwithstanding, the introduction of a relatively small, apolar, side chain, like in the case 
of 148 (entry 2), resulted in a radical change of the catalytic behavior, allowing the 
inclusion of the enamine intermediate in the organic material droplets and obtaining a 
reactivity comparable to the one reported by Hayashi for the bulky TBDPS substituent 
(entry 3). At the same time, catalyst 148 provided only racemic aldol product, thus 
showing that the steric hindrance provided by the larger substituent is necessary for the 
pyrrolidine moiety to work as a selective catalyst in presence of water. Although this may 
appear to be in conflict with the choice to adopt the benzylic side-chain, we relayed on 
the intrinsic capability of the alkylated derivative of 90 to efficiently carry out the catalytic 
process, due to its peculiar turned structure, and we hypothesized that the benzyl group 
would have simply favored its access into the organic layer.       
 
 
Scheme 41. Synthesis of the new building block 152 and of catalyst 148  
 
The hydroxyproline derivative 152, the new alkylated building block for the synthesis of 
new catalysts, was readily synthesized through the complete benzylation of Boc-Hyp-OH 
(149) using silver (I) oxide; the yield of this step is moderate but the product of 
monobenzylation at the carboxylic acid moiety can be recovered in about 30 to 40% yield 
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and reused in a new set-up. The debenzylation of 150 at room temperature, using a H2 
balloon, in EtOAc, is selective at the carboxylic functionality and provides the desired 
building block. Moreover, catalyst 148 was easily obtained by diverting part of the 
intermediate compound 150 to the alternative synthetic pathway. The synthesis of 
tripeptide 153 can be completed in a way similar to the preparation of catalyst 90 
(scheme 42). 
ClHH2N COOBn
COOMe
N
Boc
COOH +
BocHN COOBn
COOMe
3M HCl
EtOAc
EDC/TEA
DCM, 75%
N
Boc
O
NH
BnOOC COOMe
a) 3M HCl/EtOAc
b) chromatograpic
column on SiO2 gel
30-40% yield
N
H
O
NH
BnOOC COOMe
152
rac-76
rac-76a 154
155
BnO
BnO
BnO
 
 
 
Scheme 42. Synthesis of catalyst 153 
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An important operative difference between the preparation of catalysts 90 and 153 is 
observed during the selective debenzylation step which leads to the synthesis of 
intermediate 157. In this case, we were compelled to use EtOAc as solvent, instead of 
methanol, to avoid the complete deprotection of both benzyl groups. The same effect is 
observed in the preparation of 152 from 150. This notwithstanding, in the final 
deprotection step of tripeptide 159, it was noticed that the presence of a certain amount 
of methanol was required for the reaction to proceed. For this reason, a 2:1 
EtOAc/methanol mixture was successfully used to obtain selectively peptide 153. In 
general, the presence of the Boc-group on the N-atom of the pyrrolidine ring activates the 
debenzylation of the protected hydroxyl moiety which can be turned off reducing the 
polarity of the solvent used. The successful separation of 155 from its diastereomer H-
Hyp(OBn)-▼-OBn (160) through chromatography on silica gel, allowed the preparation of  
dipeptides (161) and (162), as additional candidate organocatalysts, after the opportune 
deprotection at the C-terminus (fig. 11). 
 
 
Fig. 11. Dipeptides 161 and 162 were easily accessible after the diastereomeric separation of 155 and 160. 
 
 
 
3.2 Catalysis 
 
The novel catalyst 153 was screened in the aldol reaction between cyclohexanone and 
aromatic aldehydes. Initially, the same reaction conditions used in the case of 90, either 
for the homogeneous or for the heterogeneous process were adopted. Although such 
conditions are not the most advantageous, due to the large excess of ketone employed, 
we considered it as a possibility to directly compare the activity of the catalysts 90 and 
153 (tables 21 and 22).  
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Table 21. Catalyst 90 and 153 in the homogenous aldol reaction between 27 and aromatic aldehydes (r.t., 
20:1 cyclohexanone/water, ca. 25 equiv. of 27 and 5 equiv. of water) 
    
 
 
Table 22. Catalyst 90 and 153 in the heterogeneous aldol reaction between 27 and aromatic aldehydes (r.t., 
10:1 cyclohexanone/water, ca. 25 equiv. of 27 and 10 equiv. of water) 
 
 
Two substrate aldehydes were employed in the comparison between 90 and 153: the 
activated p-nitrobenzaldehyde and the much less reactive p-chlorobenzaldehyde. As 
expected, the difference in reaction speed observed using the two different catalysts is 
larger when we consider the heterogeneous reaction conditions. In particular, while the 
entry R1  catalyst time 
(h) 
yield 
(%) 
ee anti  
(%) 
dr 
(anti/syn) 
1  
p-NO2 (61) 
H-Pro-▲-Pro-OH (90) 12 55 87 67:33 
2 H-Hyp(OBn)-▲-Pro-OH (153) 12 72 91 90:10 
3  
p-Cl (119) 
H-Pro-▲-Pro-OH (90) 24 50 91 90:10 
4 H-Hyp(OBn)-▲-Pro-OH (153) 24 72 92 91:9 
entry R1  catalyst time 
(h) 
yield 
(%) 
ee anti  
(%) 
dr 
(anti/syn) 
1  
p-NO2 (61) 
H-Pro-▲-Pro-OH (90) 24 44 95 86:14 
2 H-Hyp(OBn)-▲-Pro-OH (153) 12 64 92 86:14 
3  
p-Cl (119) 
H-Pro-▲-Pro-OH (90) 48 - - - 
4 H-Hyp(OBn)-▲-Pro-OH (153) 24 60 94 91:9 
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reaction between p-chlorobenzaldehyde and cyclohexanone catalyzed by 90 is 
completely turned off in the heterogeneous system, it proceeds smoothly in presence of 
153 (table 22, entries 3 and 4); moreover, a higher selectivity is generally observed in the 
case of our new catalyst. Based on the enhanced activity of 153 in the heterogeneous 
aldol reaction, a reduction of the number of equivalents of ketone employed was 
attempted (table 23).    
 
Table 23. Effect of the concentration of 27 on the heterogeneous aldol reaction catalyzed by 153 (r.t., 20 
mol% of catalyst, 12 h, ca. 150 equiv. of water) 
 
 
 
 
 
 
 
                                aIn 24 hours 
 
It is interesting to observe that 153 retains a good activity using just two equivalents of 
the aldol donor 27 (entry 5). At the same time, we observed under such conditions a 
slight decline of the catalytic activity. It is possible to conclude that the conditions in 
entries 3 and 4, with five equivalents of ketone, represent the optimal compromise in this 
case. It is remarkable that in the same conditions tripeptide 90 did not show any catalytic 
activity (entry 5, table 13), confirming the hypothesis that an apolar side chain is required 
to favor the inclusion of the catalyst into the organic layer.  
entry equiv. of 
ketone 
yield 
(%) 
ee anti  
(%) 
dr 
(anti/syn) 
1 25 64 92 86:14 
2 10 74 94 91:9 
3 5 72 93 91:9 
 4a 5 92 94 91:9 
5 2 66 91 83:17 
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Having identified the optimal reaction conditions, the scope of catalyst 153 was extended 
to the heterogeneous aldol reaction between cyclic ketones and aromatic aldehydes 
(table 24).  
Table 24. Catalyst 153 in the heterogenous aldol reaction between cyclic ketones and aromatic aldehydes 
(20 mol% catalyst, r.t., water ca. 150 equiv.) 
 
 
 
 
   aWith only 10 mol% of catalyst 
 
entry R1  R equiv. 
of 
ketone 
time 
(h) 
yield 
(%) 
ee 
anti  
(%) 
ee 
syn 
(%) 
dr 
(anti/syn) 
1  
 
p-NO2 (61) 
 
 
 
 
 
 
-(CH2)3- 
5 12 72 94 - 91:9 
2 5 24 92 94 - 91:9 
3 2 12 66 91 - 83:17 
4  
o- NO2 (120) 
5 12 76 97 - 97:3 
5 2 12 72 97 - 95:5 
6 p-Cl (119) 5 24 72 96 - 94:6 
7 o-Cl (121) 5 12 60 97 - >99:1 
8 o-Br (122) 5 12 71 95 - 97:3 
9 H (163) 5 24 60 93 - 90:10 
10  
p-NO2 (123) 
 
 
-CH2OCH2- 
5 24 traces - - - 
11 10 24 62 88 83 40:60 
12 o-Br (124) 10 24 48 85 0 67:33 
13 o- NO2 (125) 10 24 85 87 - 80:20 
 14a  
p-NO2 (126) 
 
-(CH2)2- 
5 8 81 72 60 20:80 
15a 2 8 74 70 63 23:77 
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The experimental data show that 153 is an excellent catalyst for the aldol reaction 
between cyclohexanone and aromatic aldehydes (entries 1-9), obtaining good yields and 
very high enantio- and diastereoselectivity in 12 to 24 hours. The excess of ketone could 
be reduced to two equivalents for the most reactive aldehydes, although the best 
catalytic performance is generally observed in presence of five equivalents of 
cyclohexanone. Cyclopentanone (entries 14, 15) proved to be an extremely reactive aldol 
donor, allowing the reduction the reaction time to 8 hours and the catalyst load to only 
10 mol%. Unfortunately, the enantioselectivity and the syn diastereoselectivity were just 
moderate. In the case of the tetrahydropiranone 118, we obtained moderate to high 
yields and high enantioselectivity for the anti isomer, but the diastereoselectivity 
observed was generally low. It is interesting to notice that this ketone is miscible with 
water in any proportion and in presence of five equivalents of 118, the aldehyde 
substrates did not dissolve at all in the ketone/water mixture, thus inhibiting the reaction. 
For this reason the ketone load was increased to ten equivalents.   
To complete the study concerning the intermolecular aldol reaction catalyzed by 153 in 
the presence of water, we explored its behavior (together with the novel peptides 161 
and 162) in the reaction between acetone and aromatic aldehydes (scheme 27) under the 
same conditions which had been previously optimized for catalyst 90. It is useful to 
remember that similarly to what observed for the processes involving cyclic ketone 118, 
this reaction proceeds in a homogeneous acetone/water mixture. For this reason, no 
substantial difference between the newly synthesized catalyst 153 and the parent 
tripeptide 90 was expected in this case (table 25).  
 
Table 25. the aldol reaction between acetone and aromatic aldehydes catalyzed by 90, 153,  
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Surprisingly, also in the case of this process catalyst 153 showed a higher activity than 
catalyst 90 (entries 1-8), although the gap between their catalytic behavior is not as 
dramatic as in the case of the heterogeneous systems. Given the homogeneity of the 
reaction mixture, the reason for this reaction rate acceleration is not clear. The ee values 
obtained using 153 and 90 are comparable and range from good to high; the best 
selectivity was obtained in the case of the activated aromatic aldehydes. Dipeptides 161 
and 162 show a strong change in their catalytic performance, when compared to the 
related catalysts 84 or 89. Again, we observed higher yields for the benzylated catalysts 
and, in the case of 162, also a radical increase in enantioselectivity. This notwithstanding 
the overall level of selectivity provided by the two dipeptides is unsatisfactory.        
 
 
entry catalyst R time 
(h) 
yield 
(%) 
ee 
(%) 
1 H-Pro-▲-Pro-OH (90)  
p-NO2-Ph (60) 
24 89 78 (R) 
2 H-Hyp(OBn)-▲-Pro-OH (153) 6 85 88 (R)  
3 H-Pro-▲-Pro-OH (90)  
p-CF3-Ph (111) 
24 80 80 (R) 
4 H-Hyp(OBn)-▲-Pro-OH (153) 4 90 80 (R) 
5 H-Pro-▲-Pro-OH (90)  
p-Cl-Ph (108) 
24 43 80 (R) 
6 H-Hyp(OBn)-▲-Pro-OH (153) 12 60 78 (R) 
7 H-Pro-▲-Pro-OH (90)  
o-Cl-Ph (109) 
24 80 68 (R) 
8 H-Hyp(OBn)-▲-Pro-OH (153) 18 80 73 (R) 
9 H-Pro-▲-Pro-OH (90)  
o-Br-Ph (110) 
24 86 72 (R) 
10 H-Hyp(OBn)-▲-Pro-OH (153) 8 87 70 (R) 
11 H-Pro-▲-OH (84)  
p-NO2-Ph (60) 
24 47 65 (R) 
12 H-Hyp(OBn)-▲-OH (161) 24 90 51 (R) 
13 H-Pro-▼-OH (89)  
p-NO2-Ph (60) 
24 47 - 
14 H-Hyp(OBn)-▼-OH (162) 24 80 48 (R) 
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3.2.1 Intramolecular aldol reaction 
 
Finally, we tested tripeptide 153 for the intramolecular aldol reaction towards the 
synthesis of the Wieland-Meschier ketone, 56. Chloroform had shown to be a suitable 
solvent for this cyclization in the case of catalyst 90. At the same time, the enhanced 
catalytic activity of 153 in the heterogeneous intermolecular aldol reaction, prompted us 
to explore the intramolecular process in water and in presence of water (table 26) which, 
to our best knowledge, is still unreported. 
 
Table 26. Results for the intramolecular aldol reaction promoted by 90 and 153 (r.t., 24-36h, 10-20 mol% 
catalyst) 
 
 
  aDetermined through chiral GC 
 
Catalyst 153 provided the product of the intramolecular aldol reaction in excellent yield 
and selectivity, allowing the complete conversion of the starting material in only 24 hours 
using 20 mol% of catalyst (entry 3). In comparison with catalyst 90 (entry 1), a slight 
increase in enantioselectivity and a moderately lower reaction speed were observed. As 
153 can be quantitatively recovered at the end of this process using the same procedure 
entry catalyst catalyst 
load  
solvent time 
(h) 
yield 
(%) 
ee  
(%) 
1 H-Pro-▲-Pro-OH 10 mol% CHCl3 24 88 92 
2 H-Hyp(OBn)-▲-Pro-OH 10 mol% CHCl3 24  56
a   96 
3 H-Hyp(OBn)-▲-Pro-OH 20 mol% CHCl3 24 >99 96 
4 H-Pro-▲-Pro-OH 10 mol% 5:1 water/CHCl3 36 traces - 
5 H-Hyp(OBn)-▲-Pro-OH 20 mol% 5:1 water/CHCl3 36  75
a  74 
6 H-Pro-▲-Pro-OH 10 mol% water 48 - - 
7 H-Hyp(OBn)-▲-Pro-OH 20 mol% water 48 <20% - 
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employed in the intermolecular aldol reaction the catalyst load employed was raised to 
20 mol% (entries 1-3), obtaining a smooth reaction which did not require any purification 
of the final product, other than a aqueous work up to recover the catalyst. 
The use of a mixture of water and chloroform represented an interesting way to carry out 
this reaction in heterogeneous conditions (entries 4-7). Once again, tripeptide 153 
showed to be a suitable catalyst for the biphasic water/organic solvent systems, affording 
a good level of conversion in the water/CHCl3 mixture in 36 hours. Unfortunately, the 
overall catalytic performance in water or in presence of water, proved to be inferior to 
the results obtained in neat CHCl3, with no conversion at all in the organic solvent free 
condition (entries 6-7). This notwithstanding, we reported here the first enantioselective 
approach to the organocatalyzed intramolecular reaction in presence of water.  
 
3.2.2 Catalyst Recovery 
 
The quantitative catalyst recovery strategy developed for 90 was extended to 153 and the 
behavior of this tripeptide within a cycle of ten reactions was tested. 20 milligrams of 
tripeptide were used for the first round of the reactions cycle and were recovered at the 
end of each process by separating the catalyst from the products through an aqueous 
work up. The subsequent removal of water through lyophilization provided 153 for the 
next stage of the catalytic cycle. The data collected show that 153 can be successfully 
reused at least ten times, without any significant loss in yield and selectivity. At the end of 
the overall cycle 17 milligrams of catalyst were still in our hands, resulting in an average 
tripeptide recovery of about 98% for each step. This positive outcome can upset the 
negative aspect of the high catalyst load employed, as only the 1.5% of the initial amount 
of 153 was lost per reaction. 
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Table 27. Recovery and reuse of catalyst 153 (r.t., 12 h, 20 mol% catalyst) 
 
 
                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                             
a
In 10:1 acetone/water; 
b 
In water, with 5 equiv. of ketone. 
 
3.2. 3 NaCl as a useful additive for the heterogeneous aldol reaction 
 
Although a well established catalyst recovery procedure has been developed, we were 
still interested in the possibility of a drastic reduction of the catalyst load employed. 
Gryko and Saletra57c showed that the addition of NaCl and in general of “salting in” 
entry Reaction product yield 
(%) 
ee anti 
(%) 
dr 
(anti/syn) 
 
1a 
 
 
95 
 
87 
 
- 
 
2a 
 
 
91   
 
88 
 
- 
 
3b 
O2N
OH O
 
 
70 
 
93 
 
91:9 
 
4b 
O2N
OH O
 
 
69 
 
94 
 
90:10 
 
5b 
O2N
OH O
 
 
75  
 
94 
 
91:9 
 
6b 
 
 
58 
 
96 
 
>99:1 
 
7b 
 
 
78 
 
94 
 
97:3 
 
8b 
 
 
70 
 
97 
 
98:2 
 
9b 
O2N
OH O
 
 
70 
 
94 
 
91:9 
 
10a 
 
 
93 
 
87 
 
- 
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compounds could accelerate the organocatalyzed aldol reaction in water by favoring the 
aggregation of the organic material in concentrated hydrophobic pockets. In this way, it 
was possible for them to reduce the catalyst load (to 5 mol%) and the number of 
equivalents of cyclohexanone employed in the process (fig. 10). The results exposed in 
table 28 show that by substituting the aqueous phase of the heterogeneous aldol 
reaction with the same volume of a saturated NaCl solution in water, a remarkable 
acceleration of the reaction was obtained. Such achievement suggested the possibility of 
reducing the amount of catalyst employed to only 5 mol%. 
 
Table 28. Catalyst 153 in the heterogenous aldol reaction between cyclohexanone and aromatic aldehydes           
in brine (r.t., 5 equiv. of ketone, water ca. 150 equiv, 5 mol% of 153) 
 
 
 
    
 
 
 
 
               a20 mol% of catalyst 
 
Within moderate reaction times, good to high yields are reported, together with very high 
enantio- and diastereoselectivity. It is worth noticing that under such reaction conditions 
it is still possible to use our standard procedure to recover the catalyst, although a 
mixture of NaCl and our peptide is obtained, rather than the pure catalyst. Further 
investigation should be carried out to check out the possibility of recycling the aqueous 
entry R1 time 
(h) 
yield 
(%) 
ee anti  
(%) 
dr 
(anti/syn) 
1  
p-NO2 (61) 
 1a 95 94 91:9 
2 12 80 94 91:9 
3 o- NO2 (120) 12 85 92 97:3 
4 p-Cl (119) 24 70 96 92:8 
5 o-Cl (121) 12 72 98 96:4 
6 o-Br (122) 12 75 95 97:3 
CHAPTER 3   70 
 
solution containing the NaCl/catalyst mixture at the end of the reaction and reuse it for a 
new catalytic cycle, after extraction of the organic material. 
In conclusion, the addition of a lipophilic side chain to the scaffold of catalyst 90, resulted 
in tripeptide 153, that performed clearly better in the heterogeneous aldol reaction 
between cyclic ketones and aromatic aldehydes. The new molecule also reproduced or 
surpassed the activity of 90 for the homogeneous intermolecular process or in the 
intramolecular aldol reaction and can be recovered, through a well established 
extraction/lyophilization procedure. Alternatively, the aldol reaction promoted by 153 
can be successfully carried out in a saturated aqueous NaCl solution; this has the effect of 
accelerating the process and allowed us to reduce the catalyst load to only 5 mol%. 
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Chapter 4: Structural analysis 
 
The development of organocatalysis has been accompanied by a strong interest in 
understanding the mechanism of the catalytic process and the related transition state. 
Proline-catalyzed reactions have been studied in an exhaustive way in the last few 
years18, strengthening the hypothesis that the enamine complex formed between the 
catalyst and the aldol donor represents the decisive step to the enantioselective 
formation of the aldol products (fig. 1, introduction). Also in the case of the peptide-
catalyzed aldol reactions an enamine transition state has been proposed77. In our case, 
the geometry of the activated complex is strictly connected to the ability of the β-ACC to 
stabilize short amino acidic sequences. The investigation of the structural role of both 
enantiomers (▲ and ▼) of this cyclic amino acid has represented an active, intriguing 
research topic in the last few years45,49,71,75 and in the course of this work. 
 
4.1 NMR studies 
 
Although both diastereomers of the β-ACC can provide a high degree of stabilization to 
the secondary structure of short peptides41,45,49, we noticed that the catalysts we 
prepared are definitely too short to possess a unique, well defined secondary structure 
and they exist as a mixture of more conformers. This notwithstanding, the accurate 
structural analysis carried out up to date71 on tripeptides H-Pro-▼-Pro-OBn (165) and H-
Pro-Pro-▼-OBn (167) suggests that the presence of the rigid β-ACC units (fig. 17 and 19) 
has the effect of rigidifying the overall structure and results in a main conformation 
prevailing over the others, making of these molecules some excellent examples of short, 
constrained peptides. The rate at which the different rotamers interconvert is slow 
compared to the NMR time scale and this enables us to individuate the main 
conformations through 1H-NMR and 13C-NMR. A nice example of the existence of multiple 
conformations can be observed in the case of tetrapeptide H-Pro-▲-Pro-▼-OBn (164, 
precursor of catalyst 101, fig. 12, above). In this case, the splitting of the amide proton 
signals in two sets of doublets, suggests us that a major and a minor conformation are 
present in CDCl3 at room temperature in a ratio of 8:1.  
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Fig. 12. (above) Signal doubling for the amide protons of tetrapeptide H-Pro-▲-Pro-▼-OBn and for the signals of 
tripeptide H-Pro-▲-Pro-OH (below). 
8:1 8:1 
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A similar behavior is observed in the case of catalyst 90. The 1H-NMR signals of this 
tripeptide have been unequivocally assigned in CD3OH by mean of bidimensional NMR 
spectroscopy (HSQC, HMBC, NOEs). It is evident that some signals (7, 9, 10, 17) double 
because of the presence of two different populations of conformers (fig. 12, below). 
This effect was confirmed by studying the behavior of the amide proton (7) at different 
temperatures (fig. 13). As expected, cooling the probe to 0°C results in an increase of the 
7+/7- (8:1) ratio, as the structure of 90 tends to be frozen in its most energetically stable 
conformation. At about 27°C the ratio between the two populations decreases to 3:1 and 
is just 2:1 at 40°C, sign that a higher degree of rotational freedom is available at higher 
temperatures.    
 
Fig. 13. 
1
H-NMR spectra for the imidic proton of catalyst 90 at 273K, 300K, 313K (CD3OH) 
 
4.1.1 Cis/trans isomerism 
 
It is reasonable to suppose that in catalysts such as 90 or 153, an important source of 
conformational isomerism would be generated by the partially hindered rotation around 
the imidic peptide bond placed at N-terminus of proline55. This phenomenon leads to the 
formation of cis- and trans-conformers (fig. 14).   
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Fig. 14. Cis-trans isomerism for the imidic peptide bond of proline 
 
Kessler and Schmitt70 reported that bidimensional NMR techniques such as NOESY or 
ROESY can be used to identify and distinguish the cis and trans isomers by looking at the 
cross peak intensities between the α proton of the antecedent residue and the α and δ 
protons of proline respectively. In particular, the presence of a long range coupling 
between the two α protons is typical for a cis conformer. In the trans conformation this 
coupling is not present and a strong NOE signal between the δ protons of proline and the 
α proton of the preceding amino acid is observed.   
In the case of tripeptide 90 we noticed an excellent agreement between the NOESY 
spectra we recorded in CD3OH and the predicted long range interactions mentioned 
above. If we look at the magnified sections of the NOESY spectrum in fig. 15 (left), it is 
possible to notice that in the minor conformation (-) there is a cross peak between the α 
proton of the β-ACC unit (10-) and the α proton of the C-terminal proline (17-). In the 
same picture, we can see that there is not such coupling in correspondence of the major 
conformer. In the box at the right side we observe that only for the main conformer a 
strong coupling between the α proton of the β-ACC unit (10+) and the δ protons of the C-
terminal proline (14) exists. On the basis of these data we can finally conclude that the 
main conformation corresponds to the trans isomer, while the rotation of the proline 
moiety around the amide bond generates a minor conformer with a cis configuration. It is 
possible to estimate, through integration of the 1H-NMR spectrum signals, that a 3:1 
trans/cis ratio is found in CD3OD, at room temperature, for tripeptide 90.    
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Fig. 15. Magnified sections of the NOESY spectrum of 90 (CD3OD) showing the cross peaks relevant to the identification 
of the cis/trans conformers 
 
 
Fig. 16. amide proton region and NOE spectrum (CDCl3) for H-Hyp(OBn)-▲-Pro-OBn 
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In the case of tripeptide H-Hyp(OBn)-▲-Pro-OBn (fig. 16) a similar isomerism is observed, 
with a trans/cis ratio of 4.5:1 and the presence of some other minor conformations.  
In CHAPTER 1, an hairpin-shaped model catalyst (fig. 7) in which the amino and the 
carboxylic functionalities of the molecule were placed in a suitable spatial disposition to 
take simultaneously part to the catalytic process, was proposed. We also postulated that 
proline would be an ideal C-terminal amino acid, aimed at inducing, at least in part, such 
cis conformation. The discovery of the existence of a stable cis-configuration in methanol 
represents an important step forward in demonstrating the validity of this assertion. This 
notwithstanding, the NMR analysis above reported does not tell us any definitive 
information about the structure of the remaining fragments of the molecule and about 
their ability to rotate freely or being relatively fixed in space. In particular, it would be 
interesting to know if the rotation around the α and β angles in fig. 17 is hindered to any 
extent as this would be extremely relevant in understanding the role of the β-ACC unit in 
stabilizing the structure of our catalyst. It would also give us a hint about the 
conformation of the transition state of the aldol reaction promoted by 90. An outstanding 
contribution to this field has been provided by Schmid, Fleischmann, Gronwald and 
Gschwind
71 through NOE and RDC spectroscopic analysis of tripeptides H-Pro-▼-Pro-OBn 
and H-Pro-Pro-▼-OBn. This study was accompanied by molecular dynamic calculations 
based on the restraints obtained through the bidimensional NMR techniques. Their 
results are exposed in the next paragraph.   
 
 
Fig. 17. Important bond rotations in tripeptide 90 
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4.1.2 Residual dipolar coupling
72 
 
The intensity of the spin dipolar coupling between two nuclei of a molecule depends on 
their distance and on their orientation relative to the static magnetic field applied. In 
isotropic media, the molecules tumble randomly and, as a consequence, the orientational 
term averages to zero in solution. Carrying out the NMR spectra in media that can 
partially order the molecules allows us to observe a part of the orientational contribution 
to the spin coupling. This can be achieved by measuring the NMR spectra in orientating 
media like liquid crystals or polymer gels within NMR tubes. Stretching or compressing 
such gels creates anisotropic cavities that allow a partial alignment of the molecules (SAG: 
strain-induced alignment in a gel). The spin-spin coupling measured under such 
conditions contains an additional component which can be calculated by subtracting the 
scalar spin-spin coupling (measured in an isotropic solution), thus generating the residual 
dipolar coupling. RDCs are of great importance in modern spectroscopy as they contain 
information about the inter-nuclear distance and the orientation of the vector between 
the two nuclei relative to the applied magnetic field (B0). In a similar way, NOEs contacts 
provide useful distance information for structural investigations but are hampered by spin 
diffusion and are referred to distance restraints without directional reference, while RDCs 
provide orientational restraints referenced to the external magnetic field. Moreover, 
RDCs can be observed for longer inter-atomic distances, as the intensity of this coupling is 
inversely proportional to r3 (r = inter-nuclear distance) while NOEs depends on r-6. An 
interesting example of the ability of this modern spectroscopic technique to provide 
excellent structural information can be seen in fig. 18. Zhou73 showed that using RDC 
data, an excellent structure of the B-form of DNA could be obtained (right), while NOE 
spectroscopy is effective only at a shorter range (left).   
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Fig. 18. Structures of the B-form of DNA as obtained by Zhou using NOE restraints (a) or RDC restraints (b) 
 
Gschwind et al.
71
 showed that even in the case of simple tripeptides, RDCs can represent 
a useful tool to derive structural information. For this purpose, H-Pro-▼-Pro-OBn (165) 
was studied either 1H-NMR, 1H, 13C-HSQC and P.E.HSQC spectroscopy in CDCl3 and in a 
strained PDMS/CDCl3 gel. Both MD calculations, based on NOE or RDC restraints, lead to 
very similar structures in which the α and β angles of 165 show an unexpected stability, 
with the values based on the RDC analysis being identified between 175°-200° and 160°-
180° respectively (see fig. 19). These data are corroborated by the calculated Karplus 
curve for 3J(HN-Hβ) that resulted to assume the unusual value of 9.69 Hz at 240°C and of 
8.89 Hz at room temperature, sign that we are observing here a dominant molecular 
conformation. The relevant RDC and NOE restraints were used for MD studies that 
confirm a remarkable stability for tripeptide 165 for what concerns the rotation around 
the α and β angles, with an extremely narrow level of uncertainty for the RDC-calculated 
structure (fig. 19, below).  
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Fig. 19. NMR analysis of tripeptide H-Pro-▼-Pro-OBn, with the relevant RDCs (above) and MD-derived structures based 
on the RDC contacts (below). 
 
The structure obtained on the base of the RDC data fits the MD calculations carried out 
using the set of coordinates for the hydrogen atoms of the cyclopropane ring which were 
attained from the crystal structure of 166 (fig. 20, right). This represents a further proof of 
the possibility to use this method to achieve useful and precise structural data and as an 
effective tool to validate the parametrization method employed. 
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An important part of this study concerned the structural and computational investigation 
of tripeptide H-Pro-Pro-▼-OBn (167). In the case of this molecule it was not possible to 
measure the RDC spectra, as it degrades with the time to the corresponding 
diketopiperazine. This notwithstanding, it was possible to obtain a large number of useful 
NOE restraints that were used for MD calculations. The picture of 167 which emerges 
from this study shows a turned, conformationally stable peptide. 
 
 
Fig. 20. The structure of H-Pro-Pro-▼-OBn obtained by Gschwind et al. (left) and the derivate of ▼ used to obtain the 
correct parametrization (right) 
 
 
4.2 IR studies 
 
IR spectroscopy represents an important instrument for the investigation of the structure 
of proteins and peptides. It is known74 that the existence of intramolecular H-bonds, 
which are extremely relevant to the folding of the amino acidic sequence, can be 
detected on the basis of the value of the amide proton absorption. An IR absorption at 
frequencies lower than 3400 cm-1 is indicative of the presence of a H-bonded amide 
proton. Zorn75 used this concept to estimate the number of H-bonded amide protons for 
a number of short peptides (fig. 21) and was able to complete the structural information 
provided by bidimensional NMR spectroscopy, CD and MD. Another useful observation 
produced during this study was the presence of an intra-residual H-bond in 166 (IR 
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absorption at 3364 cm-1). For this molecule, although the value of the dihedral NH---O 
angle is far from the optimum of 180°, the good acceptor ability of the tertiary amide 
overcomes the disadvantage of the non-ideal bond geometry.   
 
 
Fig. 21. Integration of the IR spectrum allows to quantify the ratio between H-bonded and non H-bonded amide protons 
 
The exceptional structural stability showed by tripeptide 165 (fig. 19) as a result of the 
NMR studies, suggests that the hindered rotation around the angles α and β may involve 
the existence of a stable intra-residual H-bond for the β-ACC unit of this molecule as well. 
This may be true also for the compounds having  at the center of the amino acidic 
sequence. For this purpose, we measured the FT-IR spectra of H-Pro--Pro-OBn and H-
Pro-▼-Pro-OBn in CH2Cl2, a solvent unable to disrupt intramolecular H-bonds. The 
concentration of the probe was 10 mM, which can guarantee the absence of 
intermolecular interactions75. In both cases the amide proton absorption was observed at 
about 3320 cm-1, within the limits assumed for H-bonded protons.  
 
 
4.3 Models for the transition state 
 
The studies presented in the former paragraphs represent important advances in 
understanding the structure of the β-ACC containing peptides in CHCl3. In the future, the 
development of this method can provide useful information in investigating the structure 
of the unprotected form of catalyst 90 and 153 and their mechanism of action. This 
notwithstanding, the nature of the transition state for the aldol reaction catalyzed by 88, 
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90 or 153 is still unclear, as the structure of their enamine derivatives in the medium used 
for the reaction should be determined. This is particularly challenging in the case of the 
heterogeneous process catalyzed by 90 and 153, which takes place in a dispersion of 
organic material in water. Based on the calculations carried out by Tang76 and on the 
stereochemistry of the product of the catalytic process, other authors77,57b have adopted 
model transition states for their catalytically active pseudo-peptides that explain the anti 
selectivity observed in the case of organocatalyzed reaction between cyclohexanone and 
aldehydes. An analogous transition state can be suggested in the case of 90 and 153. In 
this case we assumed that the cis conformation observed in the case of 90 in MeOH 
represents the catalytically active configuration of our peptide, as this is the conformation 
in which the amino and carboxylic functionalities are placed in the suitable orientation to 
simultaneously take part to the catalytic event (fig. 22). In a similar way, the formation of 
the S-enantiomer in the aldol reaction between acetone and aldehydes catalyzed by 88 
can be explained through the transition state reported in fig. 23.       
 
 
Fig. 22. Model transition state for 90 and 153 in the aldol reaction between cyclohexanone and p-nitrobenzaldehyde 
 
CHAPTER 4   83 
 
Fig. 23. Model transition state for the aldol reaction between acetone and p-nitrobenzaldehyde promoted by 88 
 
 
4.4 Conclusion 
 
Short peptides were synthesized coupling proline with the racemic mixture of the two 
enantiomers of the β-ACC, ▲ and ▼, following standard amino acid coupling protocols. 
Chromatographic separation of the diastereomeric mixtures of the resulting peptides 
provided us with diastereomerically pure material and enabled the synthesis of tri- and 
tetrapeptides that were tested as organocatalyst for the aldol reaction. Since from the 
first screening rounds, the tripeptides having ▲ as a central building block (and in 
particular 90) or ▼ as the C-terminal unit (88), emerged as the most interesting and 
efficient structures. In particular, 90 showed to be a versatile catalyst performing well in 
the intramolecular aldol reaction as well as in the intermolecular aldol reaction, either in 
homogeneous or heterogeneous water/ketone mixtures. Further developments saw  the 
modification of the structure of 90 in order to produce a more lipophilic specie (153) able 
to carry out the heterogeneous aldol reaction in the presence of water between cyclic 
ketones and aromatic aldehydes with higher efficiency. This improvement allowed us to 
report shorter reaction times, to use a lower excess of ketone and to reduce the catalyst 
load to only 5 mol% in the case in which NaCl is added to the reaction mixture. A well 
established catalyst recovery procedure, through an easy extraction/lyophilization 
methodic, was applied to recuperate quantitatively tripeptides 90 and 153 at the end of 
the reaction, allowing their recycling without any loss in efficiency. Structural 
spectroscopic studies were carried out by Fleischmann, Schmid and Gschwind, showing 
that the presence of the β-ACC units confers an extraordinarily and unexpected 
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secondary structure stabilization to the tripeptides containing the ▼ amino acid as a 
central building block (165) or at its C-terminus (167). Further investigation will be aimed 
at determining the structure of the most active and versatile catalysts (90 and 153) and 
their mechanism of action. A concise view of the results obtained using catalysts 88, 90 
and 153 is presented in the following scheme (fig. 24).   
 
 
Fig. 24. Comprehensive view for the most relevant catalysis results obtained using tripeptides 88, 90 and 153 
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E.1 General Information 
 
Reactions were carried out in closed 10 mL vials following the procedure subsequently 
reported; distilled, water free solvents have been employed in all the reactions that did 
not involve the presence of water. Dry DCM for peptide coupling has been obtained from 
a molecular sieves solvent purification system. Analysis grade ketones have been 
employed in the catalysis involving water containing mixtures. Aldehyde substrates have 
been distilled before use, if liquid at room temperature. Silica gel 60 (0.063-0.200 mm) 
was used for the column chromatography. TLC analysis was carried out on silica gel 60 
F254 coated on aluminium sheets. Ninhydrine coloration was employed to check the 
reaction progress during peptide synthesis, vanilline was employed to follow the 
formation of the products of catalysis. 1H (300 MHz) and 13C (75.5 MHz) NMR spectra 
were recorded on a 300 MHz Spectrometer in CDCl3 (7.27 ppm for 
1H, 77 ppm for 13C) or 
CD3OD (3.31 ppm for 
1H, 49.1 ppm for 13C). IR spectra were recorded using a golden gate, 
single reflection, ATR system. The ee was determined by chiral HPLC on a Chiralpak-AS 
column or by chiral GC on a CP Chiralsil-Dex CB column (injector temperature, 250°C, 
detector temperature, 250°C). In the case of the products of the intermolecular aldol 
reaction, the GC analysis was carried out always after trimethylsilylation of the product. 
The trimethylsilylation was carried out directly on the GC sample, dissolved in DCM by 
addition of one drop of pure trimethylsilylimidazole. The absolute configuration was 
assigned by comparison of the optical rotation for the isolated compounds, with the 
values reported in literature. The yields reported are referred to the isolated compounds; 
in the case in which a mixture of syn and anti isomers was formed, the yields reported in 
this work are referred to the total amount of the isolated diastereomeric mixture.    
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E.2 General procedure for catalytic asymmetric aldol reaction 
 
E.2.1 Intermolecular aldol reactions of acetone 
Water free conditions: 0.01 to 0.04 mmol (5 to 20% catalyst) of the selected catalyst were 
added to 0.2 mmol of aldehyde and dissolved under N2 atmosphere in 2 ml of dry acetone 
or CHCl3/acetone mixture in a 10 ml vial. The reaction was stirred for the time indicated, 
subsequently, the solvent was evaporated and 5 mL of EtOAc and 2 mL of water were 
added to the crude material. The organic phases were extracted again with 1 mL of water, 
dried (Na2SO4), concentrated and purified on silica (3:1 hexanes/EtOAc) to yield the 
desired aldol product. 
Catalyst recovery: the combined water layers were extracted with Et2O (2 mL) and frozen 
at –20°C. Lyophilization of the sample allowed the recovery of the catalyst (90-95%), 
which could be reused without any loss in performance. 
 
Homogeneous acetone/water mixture: p-nitrobenzaldehyde (38 mg, 0.25 mmol) and 
catalyst (H–Pro-▲-Pro–OH) (17.7 mg, 0.05 mmol) were dissolved in 0.75 mL of a 3:1 
acetone/water (molar ratio 1:30:42 aldehyde/acetone/water), and the reaction mixture 
was stirred for 6 hours at room temperature. Acetone was evaporated under reduced 
pressure and EtOAc (5 mL) and water (2 mL) were added to the resulting suspension. The 
organic layers were separated, extracted with water (1 mL), dried (Na2SO4) and 
evaporated. The residue was purified on silica (3:1 hexanes/EtOAc) to yield 60 (50 mg, 
95% yield, 71% ee).  
Catalyst recovery: the combined aqueous layers were extracted with Et2O (2 mL) and 
frozen at –20°C. Lyophilization allowed the recovery of the catalyst (90-95%), which could 
be reused without any loss in performance. The following table illustrates an example of 
catalyst recycling through three catalytic processes.  
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cycle time Yield ee catalyst recovery 
1 6h 95% 71% 90% 
2 6h 92% 71% 95% 
3 6h 96% 71% 93% 
Table S-1: catalytic cycles with fresh (entry 1) and recovered (entries 2,3) catalyst. 
 
E.2.2 Intermolecular aldol reactions of cyclohexanone 
Reaction between aromatic aldehydes and cyclohexanone (homogeneous): in a 5 mL 
vial, 0.03 mmol of H–Pro-▲-Pro–OH were added to 0.15 mmol of aldehyde, followed by 
20 μL of water and 0.4 mL of ketone; the reaction was left stirring for 24 h. After this 
period 3 mL of EtOAc and 1 mL of water were added to the crude material. The organic 
phases were extracted with 1 mL of water and dried (Na2SO4), evaporated and purified on 
silica (4:1 hexanes/EtOAc) to furnish the desired aldol product.  
Catalyst recovery: the combined water layers were extracted with 2 mL Et2O and frozen 
at –20°C. Lyophilization of the sample allowed the recovery of 90-95% of the catalyst. 
 
Reaction between aromatic aldehydes and cyclohexanone (heterogeneous):  
a) in a 5 mL vial, 0.03 mmol of H–Pro-▲-Pro–OH were added to 0.15 mmol of 
aldehyde, followed by 40 μL of water and 0.4 mL of ketone; the reaction mixture 
was stirred for 48 h. After this period 3 mL of EtOAc and 1 mL of water were 
added to the crude material. The organic phases were extracted with 1 mL of 
water and dried (Na2SO4), evaporated and purified on silica (4:1 hexanes/EtOAc) 
to furnish the desired aldol product.  
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Catalyst recovery: the combined water layers were extracted with 2 mL Et2O and 
frozen at -20°C. Lyophilization of the sample allowed the recovery of 90-95% of 
the catalyst. 
b) in a 5 mL vial, 0.03 mmol of H–Hyp(OBn)-▲-Pro–OH were added to 0.15 mmol of 
aldehyde, followed by 0.4 mL of water and 5 equivalents of cyclohexanone (80 
µL); the reaction mixture was stirred for 12-24 h. After this period 3 mL of Et2O 
and 1 mL of water were added to the crude material. The organic phases were 
extracted with 1 mL of water and dried (Na2SO4), evaporated and purified on silica 
(4:1 hexanes/EtOAc) to furnish the desired aldol product.  
Catalyst recovery: the combined water layers were extracted with 2 mL Et2O and 
frozen at -20°C. Lyophilization of the sample allowed the recovery of 90-95% of 
the catalyst. 
c) in a 5 mL vial, 0.03 mmol of H–Hyp(OBn)-▲-Pro–OH were added to 0.15 mmol of 
aldehyde, followed by 0.4 mL of brine and 5 equivalents of cyclohexanone (80 µL); 
the reaction mixture was stirred for 12 h. After this period 3 mL of Et2O and 1 mL 
of water were added to the crude material. The organic phases were extracted 
with 1 mL of water and dried (Na2SO4), evaporated and purified on silica (4:1 
hexanes/EtOAc) to furnish the desired aldol product. 
 
E.2.3 Intramolecular aldol reaction 
Water free: 0.02 mmol of 90 or 0.04 mmol of 153 were added to 0.2 mmol of 55 in 1 mL 
of CHCl3. The reaction mixture was stirred at room temperature. After 24 hours the 
solvent was evaporated under reduced pressure and the crude material was dissolved in 
5 mL of EtOAc and extracted with 2 mL of water. The organic phases were dried (Na2SO4), 
evaporated and, if necessary, purified through chromatography on silica gel (2:1 
hexanes/EtOAc).  
Catalyst recovery: the water layer was washed with 2 mL Et2O and frozen at –20°C. 
Lyophilization of the sample allowed the recovery of 90-95% of catalyst that could be 
reused without any loss of catalytic activity.  
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In presence of water: 0.03 mmol of 153 were added to 0.15 mmol of 55 in 0.5 mL of 
water and 0.1 mL of CHCl3. The reaction mixture was stirred at room temperature. After 
36 hours 5 mL of EtOAc 2 mL of water were added. The organic phases were dried over 
Na2SO4, evaporated and the conversion of the starting material was estimated through 
chiral GC.  
Catalyst recovery: the water layer was washed with 2 mL Et2O and frozen at –20°C. 
Lyophilization of the sample allowed the recovery of 90-95% of catalyst that could be 
reused without any loss of catalytic activity.  
 
 
E.3 Synthesis of peptides 
 
 
 
Synthesis of H-Pro-▼-OBn (80) and H-Pro-▲-OBn (81): Racemic building block rac-76 
(2.0 g, 5.7 mmol, 1.0 equiv.) was dissolved in a saturated solution of HCl in EtOAC (c≈3 
mol/L), 20 mL, at 0°C. After stirring for 2 hours the acid was removed under reduced 
pressure, leaving a white/pinkish solid as a residue. To this deprotected building block 
rac-76a was added a solution of N-Boc-L-proline (1.5 g, 7.1 mmol, 1.25 equiv.) and 
EDC·HCl (1.4 g, 7.1 mmol, 1.25 equiv.) in DCM (25 mL) that had been stirred beforehand 
for 30 min. Using a dropping funnel TEA (0.87 mL, 6.8 mmol, 1.2 equiv.) in DCM (20 mL) 
was added over a period of 1.5 h. The mixture was stirred overnight. Then the reaction 
was quenched with water (20 mL) and the solution acidified to pH 3 using KHSO4 solution 
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(1 M), then extracted with DCM. The organic phase was extracted successively with 
NaHCO3 solution and brine, dried over Na2SO4, filtered and evaporated under reduced 
pressure. Purification by chromatography on silica gel (1:1 hexanes/EtOAc) yielded 1.78 g 
(70%) of the mixture of diastereomers 78. To this diastereomeric mixture (2.0 g, 4.5 
mmol) was added at 0°C a saturated solution of HCl in EtOAC (15 mL, c≈3 mol/L). After 
stirring for 1.5 hours the acid was removed under reduced pressure leaving a white wax 
as a residue. It was redissolved in water (20 mL) and extracted with Et2O. The aqueous 
phase was then adjusted to basic pH using NaHCO3 (saturated solution) and then 
extracted with DCM (3x20 mL). The organic phase was dried over Na2SO4, filtrated and 
evaporated under reduced pressure to yield 79 (1.52 g, 4.4 mmol, 98%). The two 
diastereomers 80 and 81 were separated using column chromatography (DCM/MeOH 
15:1) to give pure 80 (570 mg, 38% Rf=0.25) and pure 81 (570 mg, 38%, Rf=0.20) along 
with the recovered mixture 79 (380 mg). 
H-Pro-▼-OBn (80), 1H-NMR (300 MHz; CDCl3) δ: 8.45 (d, 1H); 7.35 (m, 5H); 5.15 (q, 2H); 
4.04 (m, 1H); 3.70 (m, 1H); 3.69 (m, 3H); 2.94 (m, 1H); 2.76 (m, 1H); 2.57 (m, 1H); 2.37 (m, 
1H) 2.04 (m, 1H) 1.80 (m, 1H); 1.59 (m, 1H). 13C (75.5 MHz, CDCl3) δ: 176.3, 170.1, 169.4, 
135.3, 128.6, 128.5, 128.3, 67.2, 60.5, 52.4, 47.2, 36.1, 30.7, 28.5, 26.7, 26.1. (ES-MS) for 
346.15, C18H22N2O5, (MH
+) was found: 347.1; High resolution mass (EI-MS) for 346.1529, 
C18H22N2O5, 346.1529 was found. FT-IR (film) νmax: 3322.0, 2975.3, 2955.5, 1723.4, 1673.5, 
1508.4, 1451.4, 1309.9, 1177.1; mp: 114°C. 
H-Pro-▲-OBn (81), 1H-NMR (300 MHz; CDCl3) δ: 8.42 (brs, 1H); 7.35 (m, 5H); 5.15 (q, 2H); 
4.10 (m, 1H); 3.72 (m, 1H); 3.68 (s, 3H); 3.66 (m, 1H); 2.96 (m, 1H); 2.85 (m, 1H); 2.58 (m, 
1H); 2.37 (m, 1H); 1.93 (m, 1H); 1.67 (m, 2H). 13C (75.5 MHz, CDCl3) δ: 26.3, 26.6, 28.6 
30.8, 36.2, 47.3, 52.5, 60.6, 67.4, 128.5, 128.6, 128.8, 135.4, 169.7, 170.2, 176.4; (ES-MS) 
for 346.15, C18H22N2O5, (MH
+) was found: 347.1; High resolution mass (EI-MS) for 
346.1529, C18H22N2O5, 346.1528 was found (δ = 0.3 ppm). FT-IR (film) νmax: 3325.0, 
2968.3, 2957.4, 1723.8, 1667.6, 1510.5, 1407.3, 1300.0, 1179.6; oil. 
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Synthesis of H-Pro-Pro-▼-OH (88): N-Boc-L-proline (300 mg, 1.4 mmol) was dissolved in 
DCM (10 mL) and EDC·HCl (295mg, 1.54 mmol, 1.1 equiv.) was added. After 30 min 80 
(580 mg, 1.68 mmol, 1.2 equiv.) was added and the reaction was stirred overnight. Then 
DCM (10 mL) and water (10 mL) were added and the pH was adjusted to 4 by addition of 
small amounts of KHSO4 solution (1M). The organic phase was extracted and then washed 
with NaHCO3 solution (sat.) (10 mL) and brine (10 mL). The organic phase was dried over 
Na2SO4, filtered and evaporated under reduced pressure to give 87 (495 mg, 0.91 mmol, 
65%). The preparation of 88 was completed by de-protecting the amino and carboxylic 
acid functionalities of this intermediate. Boc-group deprotection of 87 (495 mg, 0.91 
mmol) was performed as reported for 78 (360 mg, 90%). Debenzylation was carried out 
by dissolving 167 (200 mg, 0.45 mmol) in MeOH and adding Pd/C (10 m%, 20 mg). Stirring 
under H2 atmosphere was continued for 1.5 hours. After this period the Pd/C residue was 
filtered through celite and the collected solvent was evaporated to provide 88 (160 mg, 
quantitative). 
H-Pro-Pro-▼-OH (88), 1H-NMR (300 MHz; CD3OD) δ: 4.59-4.14 (m, signal doubling 
because of rotamers, 2H); 3.69 (s, 3H + m, 1H); 3.64 (m, 1H); 3.48 (m, 1H); 3.78 (m, 2H); 
2.49 (m, 1H); 2.34 (m, 1H); 2.24 (m, 2H); 2.08 (m, 6H). 13C (75.5 MHz, CD3OD) δ: (major 
conformer) 175.2, 174.3, 172.98, 169.2, 62.5, 60.6, 52.8, 47.5, 46.2, 36.2, 33.0, 30.4, 29.6, 
29.0, 26.0, 25.3. (ES-MS) for 353.1, C16H23N3O6, (MH
+) was found: 354.1; High resolution 
mass (EI-MS) for 353.1587, C16H23N3O6, 353.1584 was found (δ = 0.9 ppm). FT-IR (solid) 
νmax: 2961.5, 1725.1, 1615.5, 1517.6, 1437.8, 1409.2, 1296.5, 1195.8, 1171.2, 1045.8; mp: 
169-171°C. This product is not stable after prolonged storage. 
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Synthesis of H-Pro-▲-Pro-OH (90): 81 (500 mg, 1.44 mmol) was dissolved in DCM (10 mL) 
and then Boc2O (330 mg, 1.5 mmol, 1.5 equiv.) was added. A mixture of TEA (0.15 mL, 1.1 
mmol, 1.1 equiv.) and DMAP (18 mg, 0.15 mmol, 0.15 equiv.) in DCM (10 mL) was then 
added dropwise into the mixture over a period of 1 h, and stirring continued for 10 h. The 
reaction was quenched with water and KHSO4 solution (1 M) was used to acidify the 
solution, which was then extracted with DCM. The combined organic phases were 
extracted with brine, dried over Na2SO4, evaporated under reduced pressure to give 83 
(580 mg, 90%). The following debenzylation was performed according to the procedure 
described above for the synthesis of 88 and proceeded in quantitative yield, affording 460 
mg of 85. Dipeptide 85 (360 mg, 1.0 mmol) was then dissolved in DCM (15 mL) and 
EDC·HCl (200 mg, 1.05 mmol, 1.05 equiv.) was added to the solution. After stirring for 30 
min NH(HCl)-Pro-OBn (290 mg, 1.2 mmol, 1.2 equiv.) followed by TEA (0.17 mL, 1.2 mmol, 
1.2 equiv.) were added and the mixture was stirred for 24 h. DCM (10 mL) and water (10 
mL) were added and the pH of the aqueous phase was adjusted to 4 using a KHSO4 
solution (1M). The organic phase was washed with NaHCO3 solution (sat.) (10 mL) and 
brine (10 mL). Then it was dried over Na2SO4, filtered and evaporated under reduced 
pressure to give the protected form of 90 (380 mg, 70%). Deprotection of this 
intermediate to furnish the final peptide catalyst has been carried out as described above 
for 78 (Boc-deprotection) and 88 (debenzylation), leading to 90 (240 mg, quantitative).  
H-Pro-▲-Pro-OH (90), 1H-NMR (300 MHz; CD3OH) δ: 8.79-8.27 (bs, signal doubling 
because of rotamers, 1H); 4.24 (m, 2H); 3.93 (m, 1H); 3.78 (m, 1H); 3.73 (s, 3H); 3.48-3.65 
(m, 2H); 3.38 (m 1H); 2.50-2.69 (m, 2H); 2.28 (m, 1H); 2.20 (m, 1H); 1.97 (m, 3H); 1.90 (m, 
3H). 13C (75.5 MHz, CD3OD) δ: (major conformer) 177.0, 172.3, 171.3, 166.6, 60.9, 53.0, 
50.0, 48.8, 47.6, 36.3, 31.3, 30.9, 30.4, 26.7, 25.7, 25.0. (ES-MS) for 353.1, C16H23N3O6, 
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(MH+) was found: 354.1; High resolution mass (EI-MS) for 353.1587, C16H23N3O6, 353.1593 
was found (δ = 1.7 ppm). FT-IR (solid) νmax: 2963.4, 1725.1, 1616.7, 1438.9, 1299.1, 
1195.8, 1176,3; mp: 184-186°C.   
 
 
 
Synthesis of H-Pro-▲-OH (84): Debenzylation of 81 was carried out by dissolving it (200 
mg, 0.6 mmol) in MeOH and adding Pd/C (10 m%, 20 mg). Stirring under H2 atmosphere 
was continued for 1.5 hours. After this period the Pd/C residue was filtered through celite 
and the collected solvent was evaporated to provide 84 (150 mg, quantitative). 
H-Pro-▲-OH (84), 1H-NMR (300 MHz; CDCl3) δ: 4.27 (m, 1H); 3.72 (s, 3H); 3.57 (dd, J = 4.6; 
7.9 Hz, 1H); 3.35 (m, 2H); 2.42 (m, 1H); 2.35-2.00 (m, 5H). 13C (75.5 MHz, CDCl3) δ: 172.3, 
172.2, 170.9, 61.2, 53.0, 47.4, 36.3, 31.0, 29.6, 28.1, 24.9. High resolution mass (EI-MS) for 
256.1059, C11H16N2O5, 256.1054 was found (δ = 0.2 ppm).  FT-IR (solid) νmax: 3439, 3207, 
2955, 1678, 1639, 1543, 1146; mp: 130-132°C. 
 
 
 
Synthesis of H-Pro-▼-OH (89): Debenzylation of 80 was carried out by dissolving it (200 
mg, 0.6 mmol) in MeOH and adding Pd/C (10 m%, 20 mg). Stirring under H2 atmosphere 
was continued for 1.5 hours. After this period the Pd/C residue was filtered through celite 
and the collected solvent was evaporated to provide 89 (150 mg, quantitative). 
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H-Pro-▼-OH (89), 1H-NMR (300 MHz; CDCl3) δ: 4.27 (m, 1H); 3.72 (s, 3H); 3.62 (dd, J = 5.1; 
7.4 Hz, 1H); 3.35 (m, 2H); 2.38 (m, 1H); 2.27 (m, 2H); 2.05 (m, 3H). 13C (75.5 MHz, CDCl3) δ: 
174.2, 172.0, 170.0, 61.0, 52.8, 47.2, 36.3, 30.8, 30.6, 28.5, 25.1. High resolution mass (EI-
MS) for 256.1059, C11H16N2O5, 256.1053 was found (δ = 0.2 ppm). FT-IR (solid) νmax: 3379, 
3241, 3059, 1732, 1686, 1447, 1167; mp: 132-134°C. 
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Synthesis of H-Pro-▲-Asp-OH (91): Dipeptide 85 (360 mg, 1.0 mmol) was dissolved in 
DCM (15 mL) and EDC·HCl (200 mg, 1.05 mmol, 1.05 equiv.) was added to the solution. 
After stirring for 30 min NH2(HCl)-Asp(OBn)-OBn (420 mg, 1.2 mmol, 1.2 equiv.) followed 
by TEA (0.17 mL, 1.2 mmol, 1.2 equiv.) were added and the mixture was stirred for 24 h. 
DCM (15 mL) and water (15 mL) were added and the pH of the aqueous phase was 
adjusted to 4 using a KHSO4 solution (1M). The organic phase was washed with NaHCO3 
solution (sat.) (10 mL) and brine (10 mL). Then it was dried over Na2SO4, filtered and 
evaporated under reduced pressure to give the protected form of 91 (380 mg, 70%). 
Deprotection of this intermediate to furnish the final peptide catalyst has been carried 
out as described above for 78 (Boc-deprotection) and 88 (debenzylation), leading to 91 
(250 mg, quantitative). 
H-Pro-▲-Asp-OH (91), 1H-NMR (300 MHz; CD3OD) δ: 4.62 (m, 1H); 3.85 (m, 1H); 3.77 (s, 
3H); 3.67-3.42 (m, 2H); 3.04 (m, 1H); 2.82 (m, 1H); 2.70 (m, 1H); 2.63-2.38 (m, 3H); 2.08 
(m, 3H). 13C (75.5 MHz, D2O) δ: 174.6, 174.4, 173.3, 170.6, 59.8, 52.8, 51.2, 46.4, 34.7, 
34.5, 30.7, 29.5, 29.0, 27.1, 23.7. (ES-MS) for 371.2, C15H21N3O8, (MH
+) was found: 372.3; 
High resolution mass (PI-LSIMS) for 372.1408, C15H21N3O8, 372.1412 was found (δ = 1.1 
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ppm). FT-IR (solid) νmax: 2967.3, 2864.3, 1648.3, 1580.4, 1442.5, 1190.8. mp: 
decomposition at 240-245°C. 
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Synthesis of H-Pro-▲-Asp-OH (92): Dipeptide 85 (360 mg, 1.0 mmol) was dissolved in 
DCM (15 mL) and EDC·HCl (200 mg, 1.05 mmol, 1.05 equiv.) was added to the solution. 
After stirring for 30 min NH2(HCl)-Glu(OBn)-OBn (440 mg, 1.2 mmol, 1.2 equiv.) followed 
by TEA (0.17 mL, 1.2 mmol, 1.2 equiv.) were added and the mixture was stirred for 24 h. 
DCM (15 mL) and water (15 mL) were added and the pH of the aqueous phase was 
adjusted to 4 using a KHSO4 solution (1M). The organic phase was washed with NaHCO3 
solution (sat.) (10 mL) and brine (10 mL). Then it was dried over Na2SO4, filtered and 
evaporated under reduced pressure to give the protected form of 92 (380 mg, 70%). 
Deprotection of this intermediate to furnish the final peptide catalyst has been carried 
out as described above for 78 (Boc-deprotection) and 88 (debenzylation), leading to 92 
(260 mg, quantitative). 
H-Pro-▲-Glu-OH (92), 1H-NMR (300 MHz; CD3OD) δ: 4.41 (m, 1H); 4.20 (m, 1H); 3.71 (s, 
3H); 3.52-3.71 (m, 3H); 2.52 (m, 2H); 2.40 (m, 2H); 2.15 (m, 1H); 2.02 (m, 5H). 13C (75.5 
MHz, D2O) δ: 178.3, 174.1, 173.0, 170.6, 59.8, 54.2, 52.3, 46.4, 34.8, 31.1, 30.1, 29.5, 27.1, 
26.0, 23.7. (ES-MS) for 385.2, C16H23N3O8, (MH
+) was found: 386.0; High resolution mass 
(PI-LSIMS) for 386.1563, C16H23N3O8, 386.1567 was found (δ = 1.0 ppm). FT-IR (solid) νmax: 
2965.3, 2856.3, 1643.4, 1622.0, 1444.5, 1195.3. decomposition at 245-250°C.  
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Synthesis of H-Pro-▼-Pro-OH (93): 80 (500 mg, 1.44 mmol) was dissolved in DCM (10 mL) 
and then Boc2O (330 mg, 1.5 mmol, 1.5 equiv.) was added. A mixture of TEA (0.15 mL, 1.1 
mmol, 1.1 equiv.) and DMAP (18 mg, 0.15 mmol, 0.15 equiv.) in DCM (10 mL) was then 
added dropwise into the mixture over a period of 1 h, and stirring continued for 10 h. The 
reaction was quenched with water and KHSO4 solution (1 M) was used to acidify the 
solution, which was then extracted with DCM. The combined organic phases were 
extracted with brine, dried over Na2SO4, evaporated under reduced pressure to give 82 
(580 mg, 90%). The following debenzylation was performed according to the procedure 
described above for the synthesis of 88 and proceeded in quantitative yield, affording 460 
mg of Boc-Pro-▼-OH (102). Dipeptide 102 (360 mg, 1.0 mmol) was then dissolved in DCM 
(15 mL) and EDC·HCl (200 mg, 1.05 mmol, 1.05 equiv.) was added to the solution. After 
stirring for 30 min NH(HCl)-Pro-OBn (290 mg, 1.2 mmol, 1.2 equiv.) followed by TEA (0.17 
mL, 1.2 mmol, 1.2 equiv.) were added and the mixture was stirred for 24 h. DCM (10 mL) 
and water (10 mL) were added and the pH of the aqueous phase was adjusted to 4 using 
a KHSO4 solution (1M). The organic phase was washed with NaHCO3 solution (sat.) (10 
mL) and brine (10 mL). Then it was dried over Na2SO4, filtered and evaporated under 
reduced pressure to give the protected form of 93 (385 mg, 71%). Deprotection of this 
intermediate to furnish the final peptide catalyst has been carried out as described above 
for 78 (Boc-deprotection) and 88 (debenzylation), leading to 93 (240 mg, quantitative). 
H-Pro-▼-Pro-OH (93), 1H-NMR (300 MHz; CD3OD) δ:  4.58-4.32 (m, 1H); 4.18 (m, 1H); 
3.90 (m, 1H); 3.71 (s, 3H); 3.55 (m, 1H); 3.34 (m, 3H); 2.71 (m, 1H); 2.51 (m, 1H); 2.38 (m, 
1H); 2.18 (m, 1H); 2.02 (m, 6H). 13C (75.5 MHz, CD3Cl) δ: (major conformer) 172.5, 171.7, 
170.6, 166.2, 61.1, 54.9, 52.9, 47.2, 36.0, 31.0, 30.8, 30.5, 26.5, 25.3, 25.1. (ES-MS) for 
353.1, C16H23N3O6, (M-H
+) was found: 352.1; High resolution mass (EI-MS) for 353.1587, 
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C16H23N3O6, 353.1581 was found (δ = 1.7 ppm). FT-IR (solid) νmax: 2977.5, 1723.1, 1668.7, 
1615.6, 1438.1, 1409.2, 1293.5, 1196.4, 1169.4; mp: 169-171°C. 
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Synthesis of H-Pro-▼-Asp-OH (94): Dipeptide 102 (360 mg, 1.0 mmol) was dissolved in 
DCM (15 mL) and EDC·HCl (200 mg, 1.05 mmol, 1.05 equiv.) was added to the solution. 
After stirring for 30 min NH2(HCl)-Asp(OBn)-OBn (420 mg, 1.2 mmol, 1.2 equiv.) followed 
by TEA (0.17 mL, 1.2 mmol, 1.2 equiv.) were added and the mixture was stirred for 24 h. 
DCM (15 mL) and water (15 mL) were added and the pH of the aqueous phase was 
adjusted to 4 using a KHSO4 solution (1M). The organic phase was washed with NaHCO3 
solution (sat.) (10 mL) and brine (10 mL). Then it was dried over Na2SO4, filtered and 
evaporated under reduced pressure to give the protected form of 94 (380 mg, 70%). 
Deprotection of this intermediate to furnish the final peptide catalyst has been carried 
out as described above for 78 (Boc-deprotection) and 88 (debenzylation), leading to 94 
(250 mg, quantitative). 
H-Pro-▼-Asp-OH (94), 1H-NMR (300 MHz; CD3OD) δ: 4.62 (m, 1H); 3.85 (m, 1H); 3.77 (s, 
3H); 3.67-3.42 (m, 2H); 3.04 (m, 1H); 2.82 (m, 1H); 2.70 (m, 1H); 2.63-2.38 (m, 3H); 2.08 
(m, 3H). 13C (75.5 MHz, D2O) δ: 174.6, 174.4, 173.3, 170.6, 59.8, 52.8, 51.2, 46.4, 34.7, 
34.5, 30.7, 29.5, 29.0, 27.1, 23.7. (ES-MS) for 371.2, C15H21N3O8, (MH
+) was found: 372.3; 
High resolution mass (PI-LSIMS) for 372.1408, C15H21N3O8, 372.1412 was found (δ = 1.1 
ppm). FT-IR (solid) νmax: 2967.3, 2864.3, 1648.3, 1580.4, 1442.5, 1190.8. mp: 
decomposition at 240-245°C. 
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Synthesis of H-Pro-Pro-▲-OH (95): N-Boc-L-proline (300 mg, 1.4 mmol) was dissolved in 
DCM (10 mL) and EDC·HCl (295mg, 1.54 mmol, 1.1 equiv.) was added. After 30 min 81 
(580 mg, 1.68 mmol, 1.2 equiv.) was added and the reaction was stirred overnight. Then 
DCM (10 mL) and water (10 mL) were added and the pH was adjusted to 4 by addition of 
small amounts of KHSO4 solution (1M). The organic phase was extracted and then washed 
with NaHCO3 solution (sat.) (10 mL) and brine (10 mL). The organic phase was dried over 
Na2SO4, filtered and evaporated under reduced pressure to give Boc-Pro-Pro-▲-OBn 
(95a, 495 mg, 0.91 mmol, 65%). The preparation of 95 was completed by de-protecting 
the amino and carboxylic acid functionalities of this intermediate. Boc-group deprotection 
of 95a (495 mg, 0.91 mmol) was performed as reported for 78 (360 mg, 90%). 
Debenzylation was carried out by dissolving the intermediate generated during the 
former step (200 mg, 0.45 mmol) in MeOH and adding Pd/C (10 m%, 20 mg). Stirring 
under H2 atmosphere was continued for 1.5 hours. After this period the Pd/C residue was 
filtered through celite and the collected solvent was evaporated to provide 95 (160 mg, 
quantitative). 
H-Pro-Pro-▲-OH (95), 1H-NMR (300 MHz; CD3OD) δ: 4.59 (m, 1H); 4.47 (m, 1H); 3.76 (s, 
3H + m, 1H);  3.68 (m, 3H); 3.44 (m, 1H); 2.55 (m, 1H); 2.38 (m, 2H); 2.26 (m; 2H); 2.05 (m, 
5H). 13C (75.5 MHz, CD3OD) δ: (major conformer) 175.1, 174.6, 172.8, 169.0, 79.6, 62.3, 
52.9, 47.6, 46.3, 36.4, 30.7, 29.67, 28.6, 26.0, 25.3, 24.2; (ES-MS) for 353.1, C16H23N3O6, 
(MH+) was found: 354.1; High resolution mass (EI-MS) for 353.1587, C16H23N3O6, 353.1583 
was found (δ = 1.1 ppm). FT-IR (solid) νmax: 2956.5, 1723.1, 1617.5, 1514.6, 1437.9, 
1410.2, 1299.5, 1194.8, 1171.2; wax. This product is not stable under prolonged storage. 
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Synthesis of H-Pro-β-Ala-Pro-OH (97): N-Boc-L-proline (300 mg, 1.4 mmol) was dissolved 
in DCM (10 mL) and EDC·HCl (295 mg, 1.54 mmol, 1.1 equiv.) was added. After 30 min H-
β-Ala-OBn (300 mg, 1.68 mmol, 1.2 equiv.) was added and the reaction was stirred 
overnight. Then DCM (10 mL) and water (10 mL) were added and the pH was adjusted to 
4 by addition of small amounts of KHSO4 solution (1M). The organic phase was extracted 
and then washed with NaHCO3 solution (sat.) (10 mL) and brine (10 mL). The organic 
phase was dried over Na2SO4, filtered and evaporated under reduced pressure to give 
Boc-Pro- β-Ala-OBn (395 mg, 1.05 mmol, 75%). Debenzylation of this intermediate to 
provide 96 was carried out as reported for 88 (290 mg, quantitative). 96 (290 mg, 1.05 
mmol) was dissolved in DCM (10 mL) and EDC·HCl (220 mg, 1.16 mmol, 1.1 equiv.) was 
added. After 30 min NH(HCl)-Pro-OBn (305 mg, 1.26 mmol, 1.2 equiv.) was added and the 
reaction was stirred overnight. Then DCM (15 mL) and water (15 mL) were added and the 
pH was adjusted to 4 by addition of small amounts of KHSO4 solution (1M). The organic 
phase was extracted and then washed with NaHCO3 solution (sat.) (10 mL) and brine (10 
mL). The organic phase was dried over Na2SO4, filtered and evaporated under reduced 
pressure to give Boc-Pro- β-Ala-Pro-OBn (400 mg, 0.84 mmol, 80%). Deprotection of this 
intermediate to furnish the final peptide has been carried out as described above for 78 
(Boc-deprotection) and 88 (debenzylation), leading to 97 (230 mg, quantitative). 
H-Pro-β-Ala-Pro-OH (97), 1H-NMR (300 MHz; CD3OD) δ: 4.35 (m, 1H); 4.20 (m, 1H); 3.62 
(m, 1H); 3.53 (m, 3H); 3.34 (m, 2H); 2.66 (m, 1H); 2.49 (m, 1H); 2.38 (m, 1H); 2.24 (m, 1H); 
2.02 (m, 5H); 1.88 (m, 1H). 13C (75.5 MHz, CD3OD) δ: 177.4, 171.8, 169.8, 62.8, 61.2, 47.4, 
36.7, 34.0, 32.8, 31.0, 30.7, 25.7, 25.2. (ES-MS) for 283.1, C13H21N3O4, (MH
+) was found: 
284.1; High resolution mass (EI-MS) for 283.1532, C13H21N3O4, 283.1531 was found (δ = 
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0.3 ppm). FT-IR (solid) νmax: 2958.3, 2744.4, 1622.7, 1556.6, 1445.7, 1303.5, 1195.3, 
1169.4; wax. 
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Synthesis of H-Pro-▲-Pro-▼-OH (101): To a solution of 85 (300 mg, 0.84 mmol) in 15 mL 
of DCM, EDC·HCl (180 mg, 0.93 mmol, 1.1 equiv.) was added. After 30 min 80 (350 mg, 1 
mmol, 1.2 equiv.) was added and the reaction was stirred overnight. Then DCM (10 mL) 
and water (10 mL) were added and the pH was adjusted to 4 by addition of small amounts 
of KHSO4 solution (1M). The organic phase was extracted and then washed with NaHCO3 
solution (sat.) (10 mL) and brine (10 mL). The organic phase was dried over Na2SO4, 
filtered and evaporated under reduced pressure to give Boc-Pro-▲-Pro-▼-OBn (480 mg, 
0.7 mmol, 70%). Deprotection of this intermediate to furnish the final peptide has been 
carried out as described above for 78 (Boc-deprotection) and 88 (debenzylation), leading 
to 101 (300 mg, 85%). 
H-Pro-▲-Pro-▼-OH (101), 1H-NMR (300 MHz; CD3OD) δ: 4.20 (m, 2H); 3.77 (m, 1H); 3.73 
(s, 3H); 3.71 (s, 3H); 3.48 (m, 2H); 3.32 (m, 2H); 2.73-2.55 (m, signal doubling because of 
rotamers, 2H); 2.47 (m, 1H); 2.37 (m, 1H); 2.25 (m, 1H); 2.04 (m, 3H); 1.92 (m, 4H). 13C 
(75.5 MHz, CD3OD) δ: 175.7, 172.3, 172.1, 171.4, 171.0, 167.7, 62.2, 60.8, 53.1, 53.0, 48.9, 
47.6, 36.6, 36.1, 31.2, 31.0, 30.8, 28.1, 26.7, 26.6, 25.4, 25.0. (ES-MS) for 494.2, 
C22H30N4O9, (MH
+) was found: 495.2; High resolution mass (EI-MS) for 494.2013, 
C22H30N4O9, 494.2003 was found (δ = 2.0 ppm). FT-IR (solid) νmax: 2988.5, 2976.5, 1734.1, 
1687.1, 1669.4, 1616.4, 1612.5, 1423.6, 1412.5, 1294.6, 1200.5, 1198.2, 1167.5; mp: 230-
232°C. 
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Synthesis of H-Pro-▼-Pro-Pro-OH (104): 102 (320 mg, 0.9 mmol) was dissolved in DCM 
(10 mL) and EDC·HCl (180 mg, 0.95 mmol, 1.05 equiv.) was added. After 30 min 103 (365 
mg, 1.08 mmol, 1.2 equiv.) was added and the reaction was stirred overnight. Then DCM 
(10 mL) and water (10 mL) were added and the pH was adjusted to 4 by addition of small 
amounts of KHSO4 solution (1M). The organic phase was extracted and then washed with 
NaHCO3 solution (sat.) (10 mL) and brine (10 mL). The organic phase was dried over 
Na2SO4, filtered and evaporated under reduced pressure to give Boc-Pro-▼-Pro-Pro-OBn 
(460 mg, 0.72 mmol, 80%). Deprotection of this intermediate to furnish the final peptide 
has been carried out as described above for 78 (Boc-deprotection) and 88 
(debenzylation), leading to 104 (275 mg, 0.61 mmol, 85%). 
H-Pro-▼-Pro-Pro-OH (104), 1H-NMR (300 MHz; CD3OD) δ: 4.46-3.94 (m, signal doubling 
because of rotamers, 3H); 3.72 (s, 3H); 3.66 (m, 2H); 3.58 (m, 2H), 3.49 (m, 2H); 3.37 (m, 
1H); 2.67 (m, 2H); 2.27 (m, 3H); 2.04 (m, 9H). 13C (75.5 MHz, CD3OD) δ: 172.4, 172.1, 
171.4, 168.7, 166.1, 71.4, 61.8, 53.0, 50.5, 47.4, 46.3, 36.0, 31.6, 31.3, 30.7, 30.3, 29.2, 
28.8, 26.2, 25.2, 24.2, (ES-MS) for 450.2, C22H30N4O9, (MH
+) was found: 451.2; High 
resolution mass (EI-MS) for 450.2114, C21H30N4O7, 450.2108 was found (δ = 1.3 ppm). FT-
IR (film) νmax: 2983.5, 2960.4, 1720.1, 1687.1, 1618.4, 1422.6, 1411.0, 1294.6, 1200.5, 
1198.2, 1167.5; oil. 
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Synthesis of H-Hyp(OBn)-OH (148) and Boc-Hyp(OBn)-OH (152): 149 (1.9 g, 8.2 mmol) is 
dissolved in 15 mL of DMF. Ag2O is added to this solution at 0°C (4.75 g, 20.5 mmol, 2.5 
equiv.) and the reaction is left stirring for 24 hours. After this period, the inorganic 
precipitates are filtrated and water (30 mL) and Et2O (20 mL) are added to the resulting 
solution. The organic layer is washed with 15 mL of water, dried over Na2SO4 and 
evaporated to yield a oil that is purified through column chromatography on silica gel (1:1 
Hexanes/Et2OAc) affording 1.85 g of 150 (4.4 mmol, 55%) along with 1.1 g of the mono-
benzylated product Boc-Hyp(OH)-OBn (3.4 mmol, 43%). 150 (200 mg, 0.5 mmol) is Boc-
deprotected following the same procedure used for the deprotection of 78, obtaining 151 
(140 mg, 0.45 mmol, 90%). 151 (140 mg, 0.45 mmol)  was dissolved in MeOH and Pd/C 
(10 m%, 14 mg) was added. Stirring under H2 atmosphere was continued for 30 min. After 
this period the Pd/C residue was filtered through celite and the collected solvent was 
evaporated to provide 148 (100 mg, quantitative). The remaining amount of 150 (1.65 g, 
3.9 mmol) was dissolved in EtOAC and Pd/C (10 m%, 170 mg) was added. Stirring under 
H2 atmosphere was continued for 1 hour. After this period the Pd/C residue was filtered 
through celite and the collected solvent was evaporated to provide 152 (1.19 g, 3.7 mmol, 
95%). 
H-Hyp(OBn)-OH (148), 1H-NMR (300 MHz; CD3OD) δ: 7.45-7.15 (m, 5H); 4.52 (s, 2H); 4.27 
(brs 1H); 4.03 (m, 2H); 2.51 (m, 1H); 2.00 (m, 1H); 1.28 (m, 2H). 13C (75.5 MHz, CD3OD) δ: 
177.5, 139.3, 130.3, 129.5, 129.1, 129.0, 128.9, 72.0, 61.7, 52.2, 37.0, 23.4. (ES-MS) for 
221.1, C12H16NO3, (MH
+) was found: 221.9; High resolution mass (EI-MS) for 221.1130, 
C12H16NO3, 221.1130 was found (δ = 0). FT-IR (solid) νmax: 2946.3, 2773.4, 1620.7, 1566.6, 
1449.7, 1313.5, 1185.3, 1189.4; mp: 190-191°C. 
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Synthesis of H-Hyp(OBn)-▲-Pro-OH (153): Racemic building block rac-76 (2.0 g, 5.7 
mmol, 1.0 equiv.) was dissolved in a saturated solution of HCl in EtOAC (c≈3 mol/L), 20 
mL, at 0°C. After stirring for 2 hours the acid was removed under reduced pressure, 
leaving a white/pinkish solid as a residue. To this deprotected building block rac-76a was 
added a solution of 152 (1.3 g, 5.7 mmol, 1.0 equiv.) and EDC·HCl (805 g, 6.0 mmol, 1.05 
equiv.) in DCM (25 mL) that had been stirred beforehand for 30 min. Using a dropping 
funnel TEA (0.87 mL, 6.8 mmol, 1.2 equiv.) in DCM (20 mL) was added over a period of 1.5 
h. The mixture was stirred overnight. Then the reaction was quenched with water (20 mL) 
and the solution acidified to pH 3 using KHSO4 solution (1 M), then extracted with DCM. 
The organic phase was extracted successively with NaHCO3 solution and brine, dried over 
Na2SO4, filtered and evaporated under reduced pressure. Purification by chromatography 
on silica gel (3:1 hexanes/EtOAc) yielded 2.36 g (4.3 mmol, 75%) of the mixture of 
diastereomers 154. The Boc-deprotection of this mixture was carried out as reported in 
the case of 78, to yield H-Hyp(OBn)-▲/▼-OBn (154a, 1.94 g, 4.21 mmol, 98%). The two 
diastereomers 160 and 155 were separated through column chromatography on silica gel 
(DCM/MeOH 30:1) to give pure 160 (810 mg, 42% Rf=0.40) and pure 155 (620 mg, 32%, 
Rf=0.35) along with the recovered mixture 154a (480 mg, 25%). 155 (500 mg, 1.1 mmol) 
was dissolved in DCM (10 mL) and then Boc2O (360 mg, 1.65 mmol, 1.5 equiv.) was 
added. TEA (0.17 mL, 1.2 mmol, 1.1 equiv.) in DCM (10 mL) was then added dropwise into 
this mixture over a period of 1 h, and stirring continued for 10 h. The reaction was 
quenched with water and KHSO4 solution (1 M) was used to acidify the solution, which 
was then extracted with DCM. The combined organic phases were extracted with brine, 
dried over Na2SO4, evaporated under reduced pressure to give Boc-Hyp(OBn)-▲-OBn 
(545 mg, 1.0 mmol, 90%). This intermediate (545 mg, 1.0 mmol) was dissolved in EtOAC 
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and Pd/C (10 m%, 55 mg) was added. Stirring under H2 atmosphere was continued for 1 
hour. After this period the Pd/C residue was filtered through celite and the collected 
solvent was evaporated to provide 157 (455 mg, 0.99 mmol, 99%). Dipeptide 157 (200 
mg, 0.43 mmol) was then dissolved in DCM (10 mL) and EDC·HCl (90 mg, 0.45 mmol, 1.05 
equiv.) was added to the solution. After stirring for 30 min NH(HCl)-Pro-OBn (160 mg, 
0.65 mmol, 1.5 equiv.) followed by TEA (0.09 mL, 0.65 mmol, 1.5 equiv.) were added and 
the mixture was stirred for 36 h. DCM (10 mL) and water (10 mL) were added and the pH 
of the aqueous phase was adjusted to 4 using a KHSO4 solution (1M). The organic phase 
was washed with NaHCO3 solution (sat.) (10 mL) and brine (10 mL). Then it was dried over 
Na2SO4, filtered and evaporated under reduced pressure to give 158 (140 mg, 0.22 mmol, 
50%). 158 (140 mg, 0.22 mmol) is Boc-deprotected following the same procedure used for 
the deprotection of 78, obtaining 159 (105 mg, 0.2 mmol, 90%). 159 (105 mg, 0.2 mmol) 
was dissolved in 5 mL of a 2:1 EtOAc/MeOH mixture and Pd/C (10 m%, 10 mg) was added. 
Stirring under H2 atmosphere was continued for 2 hours. After this period the Pd/C 
residue was filtered through celite and the collected solvent was evaporated to provide 
153 (92 mg, quantitative). 
H-Hyp(OBn)-▲-Pro-OH (153), 1H-NMR (300 MHz; CD3OD) δ: 7.42-7.18 (m, 5H); 4.73-4.45 
(m, 3H); 4.44-4.01 (m, 2H); 4.00-3.82 (m, 1H); 3.81-3.65 (m, 4H); 3.64-3.28 (m, 3H); 2.80-
2.41 (m, 3H); 2.40-2.75 (m, 5H). 13C (75.5 MHz, CD3OD) δ (major conformer): 172.5, 171.2, 
167.6, 166.5, 139.0, 129.54, 129.51, 129.02, 129.01, 128.9, 79.0, 71.9, 59.9, 52.9, 36.6, 
36.4, 36.2, 31.2, 29.1, 26.9, 25.7, 23.9. (ES-MS) for 459.1, C23H29N3O7, (MH
+) was found: 
460.0; High resolution mass (EI-MS) for 459.2006, C23H29N3O7, 459.2005 was found (δ = 
0.2 ppm). FT-IR (solid) νmax: 2958.3, 2744.4, 1622.7, 1556.6, 1445.7, 1303.5, 1195.3, 
1169.4; solid, mp: decomposition at ca. 200°C. 
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Synthesis of H-Hyp(OBn)-▲-OH (161): Debenzylation of 155 was carried out by dissolving 
it (50 mg, 0.11 mmol) in a 2:1 EtOAc/MeOH mixture and adding Pd/C (10 m%, 5 mg). 
Stirring under H2 atmosphere was continued for one hour. After this period the Pd/C 
residue was filtered through celite and the collected solvent was evaporated to provide 
161 (40 mg, quantitative). 
H-Hyp(OBn)-▲-OH (161), 1H-NMR (300 MHz; CD3OD) δ: 7.43-7.11 (m, 5H); 4.70-4.29 (m, 
4H); 3.85-3.50 (m, 4H); 3.44 (m, 1H); 3.31 (m, 1H); 2.56 (m, 1H); 2.30 (m, 2H); 2.04 (m, 
1H). 13C (75.5 MHz, CD3OD) δ (major conformer): 173.8, 172.4, 170.3, 138.9, 129.3, 129.2, 
129.1, 78.4, 72.0, 60.3, 52.6, 52.2, 36.2, 36.0, 30.0, 28.1. (ES-MS) for 362.1, C18H22N2O6, 
(MH+) was found: 363.0; High resolution mass (PI-LSIMS) for 362.1556, C18H22N2O6, 
362.1560 was found (δ = 1.2 ppm). FT-IR (solid) νmax: 2956.3, 2798.4, 1667.7, 1598.6, 
1466.7, 1345.5, 1198.3, 1107.4; solid, mp: 220-221°C. 
 
 
 
Synthesis of H-Hyp(OBn)-▼-OH (162): Debenzylation of 160 was carried out by dissolving 
it (50 mg, 0.11 mmol) in a 2:1 EtOAc/MeOH mixture and adding Pd/C (10 m%, 5 mg). 
Stirring under H2 atmosphere was continued for one hour. After this period the Pd/C 
residue was filtered through celite and the collected solvent was evaporated to provide 
162 (40 mg, quantitative). 
H-Hyp(OBn)-▼-OH (162), 1H-NMR (300 MHz; CD3OD) δ: 7.43-7.11 (m, 5H); 4.72-4.31 (m, 
4H); 3.80-3.55 (m, 4H); 3.47 (m, 1H); 3.29 (m, 1H); 2.64 (m, 1H); 2.31 (m, 2H); 2.07 (m, 
1H). 13C (75.5 MHz, CD3OD) δ (major conformer): 173.9, 172.7, 170.6, 139.1, 129.5, 129.0, 
129.0, 78.7, 72.2, 60.1, 52.9, 52.4, 36.7, 36.3, 30.3, 28.2. (ES-MS) for 362.1, C18H22N2O6, 
(MH+) was found: 363.0; High resolution mass (PI-LSIMS) for 362.1556, C18H22N2O6, 
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362.1566 was found (δ = 2.7 ppm). FT-IR (solid) νmax: 2956.3, 2798.4, 1667.7, 1598.6, 
1466.7, 1345.5, 1198.3, 1107.4; solid, mp: 223-225°C. 
 
 
E.4 Catalysis products 
 
 
4-Hydroxy-4-phenyl-butan-2-one (52), [α]20D = -51.3 (c = 1.0, CHCl3) for (S)-enantiomer, 
79% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.27-7.38 (m, 5H); 5.15 (m, 1H); 3.32 (d, J = 3.0 Hz, 
1H); 2.87 (m, 2H); 2.21 (s, 3H). 13C (75.5 MHz, CDCl3) δ: 209.2, 142.7, 128.6, 127.7, 125.7, 
69.9, 52.0, 30.8. Enantiomeric excess determined by chiral GC as reported in the general 
information, at 120°C, tR is 9.77 min for (S)-enantiomer, 10.12 min for (R)-enantiomer. 
 
 
4-Hydroxy-4-(4'-nitrophenyl)-butan-2-one (60), [α]20D = -51.4 (c = 0.5, CHCl3) for (S)-
enantiomer, 88% ee. 1H-NMR (300 MHz; CDCl3) δ: 8.15 (d, J = 6.8 Hz, 2H); 7.46 (d, J = 6.8 
Hz, 2H); 5.18 (m, 1H); 3.65 (d, J = 3.2 Hz, 1H); 2.89 (m, 2H); 2.18 (s, 3H). 13C (75.5 MHz, 
CDCl3) δ: 208.6, 150.2, 147.4, 129.1, 126.7, 124.5, 123.9, 69.2, 51.9, 31.2. Enantiomeric 
excess determined by chiral GC as reported in the general information, at 165°C, tR is 
13.65 min for (S)-enantiomer, 14.04 min for (R)-enantiomer. 
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4-Hydroxy-4-(4'-chlorophenyl)-butan-2-one (108), [α]22D = -67.8 (c = 1.0, CHCl3), for (S)-
enantiomer, 84% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.27-7.21 (m, 4H); 5.08 (m, 1H); 3.31 
(brd, 1H); 2.78 (m, 2H); 2.15 (s, 3H). 13C (75.5 MHz, CDCl3) δ: 219.0, 141.2, 133.4, 128.7, 
127.0, 69.2, 51.8, 30.8. Enantiomeric excess determined by chiral GC as reported in the 
general information, at 140°C, tR is 10.80 min for (S)-enantiomer, 11.15 min for (R)-
enantiomer. 
 
 
4-Hydroxy-4-(2'-chlorophenyl)-butan-2-one (109), [α]20D = -101.3 (c = 1.2, CHCl3) for (S)-
enantiomer, 80% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.61 (m, 1H); 7.44-7.18 (m, 3H); 5.50 
(m, 1H); 3.61 (brs, 1H); 3.01-2.63 (m, 2H); 2.22 (s, 3H). 13C (75.5 MHz, CDCl3) δ: 209.3, 
140.1, 131.1, 129.3, 128.6, 127.3, 127.1, 66.6, 50.0, 30.6. Enantiomeric excess determined 
by chiral GC as reported in the general information, at 120°C, tR is 17.86 min for (S)-
enantiomer, 18.38 min for (R)-enantiomer. 
 
 
4-Hydroxy-4-(2'-bromophenyl)-butan-2-one (110), [α]22D = -77.8 (c = 1.5, CHCl3), for (S)-
enantiomer, 82% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.61-7.41 (m, 4H); 5.44 (m, 1H); 3.56 
(brs, 1H); 2.99 (m, 1H); 2.65 (m, 1H); 2.22 (s, 3H). 13C (75.5 MHz, CDCl3) δ: 204.2, 141.6, 
137.6, 129.0, 127.9, 127.3, 121.2, 68.8, 50.1, 30.6. Enantiomeric excess determined by 
chiral GC as reported in the general information, at 130°C, tR is 16.64 min for (S)-
enantiomer, 17.12 min for (R)-enantiomer.   
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4-Hydroxy-4-(4'-trifluoromethyl)-butan-2-one (111), [α]22D = -47.8 (c = 1.5, CHCl3), for (S)-
enantiomer, 87% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.60 (d, J = 8.0 Hz, 2H); 7.48 (d, J = 8.0 
Hz, 2H); 5.20 (m, 1H); 3.62 (brs, 1H); 2.84 (d, J = 6.3 Hz, 1H); 2.18 (s, 3H). 13C (75.5 MHz, 
CDCl3) δ: 208.8, 146.7, 129.6, 125.9, 125.5, 122.3, 69.2, 52.0, 30.7. Enantiomeric excess 
determined by chiral GC as reported in the general information, at 120°C, tR is 9.04 min 
for (S)-enantiomer, 9.43 min for (R)-enantiomer.   
 
 
4-Hydroxy-4-(2'-nitrophenyl)-butan-2-one (112), [α]20D = +91.2 (c = 1.0, CHCl3) for (R)-
enantiomer, 91% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.93 (m, 2H); 7.67 (m, 1H); 7.44 (m, 
1H); 5.68 (dd, J = 1.8; J = 9.7, 1H); 3.73 (brs, 1H); 3.18 (d, J = 1.8, 1H); 2.72 (m, 1H); 2.24 (s, 
3H). 13C (75.5 MHz, CDCl3) δ: 208.9, 147.1, 138.4, 133.9, 128.3, 128.2, 124.5, 65.6, 51.1, 
30.5. Enantiomeric excess determined by chiral GC as reported in the general 
information, at 160°C, tR is 8.15 min for (S)-enantiomer, 10.55 min for (R)-enantiomer. 
 
 
4-Hydroxy-4-(cyclohexyl)-butan-2-one (113), [α]22D = -35.3 (c = 2.0, CHCl3), for (S)-
enantiomer 82% ee. 1H-NMR (300 MHz; CDCl3) δ: 3.82 (m, 1H); 2.89 (brs, 1H); 2.53 (m, 
2H); 2.18 (s, 3H); 1.75-1.60 (m, 5H); 1.25-0.95 (m, 6H). 13C (75.5 MHz, CDCl3) δ: 210.7, 
71.9, 47.5, 42.8, 30.7, 29.0, 28.1, 26.4, 26.2, 25.9. Enantiomeric excess determined by 
chiral GC as reported in the general information, at 100°C, tR is 32.31 min for (S)-
enantiomer, 33.11 min for (R)-enantiomer. 
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4-Hydroxy-4-(4'-fluoro)-butan-2-one (114), [α]22D = +55.6 (c = 1.5, CHCl3), for (R)-
enantiomer, 72% ee. 1H-NMR (300 MHz; CDCl3) δ: 7.30 (m, 2H); 7.03 (m, 2H); 5.13 (m, 1H); 
3.30 (brs, 1H); 2.83 (m, 1H); 2.21 (s, 3H). 13C (75.5 MHz, CDCl3) δ: 209.1, 163.9, 138.4, 
127.4, 115.5, 69.2, 51.9, 30.8. Enantiomeric excess determined by chiral GC as reported in 
the general information, at 130°C, tR is 6.71 min for (S)-enantiomer, 7.03 min for (R)-
enantiomer. 
 
 
2-(Hydroxy(4-nitrophenyl)methyl)cyclohexanone (61), [α]22D = +11.8 (c = 1.0, CHCl3), for 
anti/syn = 6:1 and 95% ee (anti). 1H-NMR (300 MHz; CDCl3) δ (anti): 8.12 (d, J = 8.7 Hz, 
2H); 7.34 (d, J = 8.7 Hz, 2H); 4.82 (d, 1H); 4.05 (brs, 1H); 2.53 (m, 1H); 2.38 (m, 2H); 2.01 
(m, 1H); 1.68-1.23 (m, 5H). 13C (75.5 MHz, CDCl3) δ: 214.7, 148.5, 147.5, 127.9, 123.5, 
73.9, 57.2, 42.7, 30.7, 27.6, 24.7. Diastereomeric ratio and enantiomeric excess 
determined by chiral GC as reported in the general information, at 170°C, tR is 39.84 and 
40.61 min (major) for the anti diastereomer, 44.59 and 46.10 for the syn diastereomer. 
 
 
2-(Hydroxy(4-chlorophenyl)methyl)cyclohexanone (119), [α]22D = +20.4 (c = 1.0, CHCl3), 
for anti/syn = 9:1 and 91% ee (anti). 1H-NMR (300 MHz; CDCl3) δ (anti): 7.30 (d, J = 8.4 Hz, 
2H); 7.27 (d, J = 8.4 Hz, 2H); 4.76 (d, 1H); 3.97 (brs, 1H); 2.60-2.44 (m, 2H); 2.35 (m, 1H); 
2.10 (m, 1H); 1.82-1.45 (m, 4H); 1.29 (m, 1H). 13C (75.5 MHz, CDCl3) δ: 215.3, 139.5, 133.6, 
128.6, 128.4, 74.2, 57.4, 42.7, 30.7, 27.7, 24.7. Diastereomeric ratio and enantiomeric 
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excess determined by chiral GC as reported in the general information, at 145°C, tR is 
36.71 and 37.47 min (major) for the anti diastereomer, 39.78 and 41.89 for the syn 
diastereomer. 
 
 
2-(Hydroxy(2-nitro)methyl)cyclohexanone (120), [α]22D = +24.9 (c = 0.8, CHCl3), for 
anti/syn = 30:1 and 98% ee (anti). 1H-NMR (300 MHz; CDCl3) δ (anti): 7.80 (m, 2H); 7.64 
(m, 1H); 7.43 (m, 1H); 5.45 (d, J = 7.0 Hz, 1H); 4.19 (brs, 1H); 2.75 (m, 1H); 2.35 (m, 2H); 
2.11 (m, 1H); 1.87-1.55 (m, 5H). 13C (75.5 MHz, CDCl3) δ: 215.0, 148.7, 136.4, 133.3., 
128.9, 128.1, 124.0, 69.6, 57.1, 42.8, 30.8, 27.8, 25.1. Diastereomeric ratio and 
enantiomeric excess determined by chiral HPLC on a CHIRALCEL OD-H column (95:5 
Hexane/i-PrOH, 1 ml/min) tR is 18.07 and 21.59 min (major) for the anti diastereomer, 
11.57 and 13.59 min for the syn diastereomer. 
 
 
2-(Hydroxy(2-chlorophenyl)methyl)cyclohexanone (121), [α]22D = +19.4 (c = 2.7, CHCl3), 
for anti/syn = 70:1 and 98% ee (anti). 1H-NMR (300 MHz; CDCl3) δ (anti):  7.53 (m, 1H); 
7.29 (m, 2H); 7.19 (m, 1H); 5.33 (dd, J = 3.7; J = 8.2, 1H); 4.05 (d, J = 3.7, 1H); 2.66 (m, 1H); 
2.44 (m, 1H); 2.32 (m, 1H); 2.07 (m, 1H); 1.84-1.50 (m, 5H). 13C (75.5 MHz, CDCl3) δ: 215.2, 
139.1, 132.9, 129.2, 128.8, 128.3, 127.3, 70.4, 57.6, 42.7, 30.4, 27.8, 24.9. Diastereomeric 
ratio and enantiomeric excess determined by chiral GC as reported in the general 
information, at 160°C, tR is 13.57 and 14.98 min (major) for the anti diastereomer, 17.29 
and 18.77 for the syn diastereomer. 
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2-(Hydroxy(2-bromophenyl)methyl)cyclohexanone (122), [α]22D = +14.0 (c = 2.5, CHCl3), 
for anti/syn = 90:1 and 95% ee (anti). 1H-NMR (300 MHz; CDCl3) δ (anti): 7.50 (m, 2H); 
7.34 (m, 1H); 7.13 (m, 1H); 5.30 (m, J = 7.7, 1H); 3.85 (brs, 1H); 2.76 (m, 1H); 2.44 (m, 2H); 
2.08 (m, 1H); 1.88-1.46 (m, 5H). 13C (75.5 MHz, CDCl3) δ: 215.3, 140.8, 132.5, 129.1, 128.8, 
127.9, 123.4, 72.9, 57.7, 42.8, 30.6, 27.8, 25.0. Diastereomeric ratio and enantiomeric 
excess determined by chiral GC as reported in the general information, at 160°C, tR is 
18.36 and 20.24 min (major) for the anti diastereomer, 23.89 and 25.69 for the syn 
diastereomer. 
 
 
3-(Hydroxy(4-nitrophenyl)methyl)-tetrahydropyran-4-one (123), [α]22D = +39.0 (c = 2.2, 
CHCl3), for anti/syn = 1:2 and 87% ee (syn). 
1H-NMR (300 MHz; CDCl3) δ: 8.22 (d, J = 8.9, 
2H); 7.51 (d, J = 8.9, 2H); 5.54 (s, 0.61H, syn); 4.98 (d, 0.39H, anti); 4.23 (m, 1H); 3.77 (m, 
3H); 3.46 (m, 0.39H, anti); 2.97-2.85 (m, 1H + m, 0.61H, syn);  2.71 (m, 1H); 2.50 (m, 1H). 
13C (75.5 MHz, CDCl3) δ (syn): 207.3, 147.0, 126.4, 125.3, 122.7, 67.9, 67.3, 66.5, 56.2, 
42.1. 13C (75.5 MHz, CDCl3) δ (anti): 208.3, 146.3, 126.4, 125.3, 122.9, 70.3, 68.8, 67.3, 
56.6, 41.9. Diastereomeric ratio and enantiomeric excess determined by chiral GC as 
reported in the general information, at 180°C, tR is 26.18 and 26.57 min (major) for the 
anti diastereomer, 29.53 and 30.94 min (major) for the syn diastereomer 
 
. 
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3-(Hydroxy(2-bromo)methyl)-tetrahydropyran-4-one (124), [α]22D = +12.4 (c = 0.7, 
CHCl3), for anti/syn = 3:1 and 83% ee (anti). 
1H-NMR (300 MHz; CDCl3) δ: 7.55 (m, 2H); 
7.37 (m, 1H); 7.16 (m, 1H); 5.73 (s, 0.25H, syn); 5.30 (d, J = 6.4 Hz, 0.75H, anti); 4.23 (m, 
1H); 3.90-3.54 (m, 3H); 2.94 (m, 1H); 2.66 (m, 1H); 2.47 (m, 1H). 13C (75.5 MHz, CDCl3) δ 
(anti): 209.9, 139.8, 132.7, 129.5, 129.0, 128.4, 122.5, 70.4, 70.0, 68.4, 58.0, 43.2. 
Diastereomeric ratio and enantiomeric excess determined by chiral GC as reported in the 
general information, at 135°C, tR is 51.30 and 52.49 min (major) for the anti diastereomer, 
45.94 and 49.12 min (major) for the syn diastereomer. 
 
 
3-(Hydroxy(2-nitrophenyl)methyl)-tetrahydropyran-4-one (125), [α]22D = +36.5 (c = 0.7, 
CHCl3), for anti/syn = 4:1 and 86% ee (anti). 
1H-NMR (300 MHz; CDCl3) δ: 7.93 (dd, J = 8.4 
Hz, 0.8 Hz, 1H); 7.81 (t, J = 7.2 Hz, 1H); 7.68 (m, 1H); 7.46 (m, 1H); 6.03 (s, 0.2H, syn); 5.48 
(d, J = 6.8 Hz, 0.8H, anti); 4.23 (m, 1H); 4.06 (brs, 1H); 3.83-3.79 (m, 2H); 3.10-3.04 (m, 
1H); 2.72-2.64 (m, 1H); 2.54-2.49 (m, 1H). 13C (75.5 MHz, CDCl3) δ (anti): 209.6, 148.1, 
136.1, 133.6, 128.8, 125.0, 70.5, 68.4, 68.2, 57.9, 43.2. Diastereomeric ratio and 
enantiomeric excess determined by chiral HPLC on a OD/ODH column (95:5 Heptane/i-
PrOH, 0.5 ml/min). tR is 84.64 (major) and 94.06 min (minor) for the anti diastereomer, 
52.14 and 64.47 min (major) for the syn diastereomer. 
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2-(Hydroxy(4-nitrophenyl)methyl)cyclopentanone (126), 
1H-NMR (300 MHz; CDCl3) δ: 
8.18 (d, J = 8.7 Hz, 2H); 7.51 (d, J = 8.7 Hz, 2H); 5.41 (d, 0.67H, syn); 4.83 (d, 0.34H, anti); 
4.78 (brs, 0.34H, anti); 2.74 (brs, 0.67H, syn); 2.50-1.67 (m, 7H). 13C (75.5 MHz, CDCl3) δ 
(syn): 219.6, 150.2, 127.3, 126.4, 123.7, 70.5, 56.2, 39.0, 22.4, 20.4. Diastereomeric ratio 
and enantiomeric excess determined by chiral GC as reported in the general information, 
at 165°C, tR is 31.42 and 32.33 min (major) for the syn diastereomer, 36.33 and 39.16 min 
(major) for the anti diastereomer. 
 
 
2-(Hydroxymethyl)cyclohexanone (163), [α]22D = +24.7 (c = 0.6, CHCl3), for anti/syn = 9:1 
and 93% ee (anti). 1H-NMR (300 MHz; CDCl3) δ (anti):  7.31 (m, 5H); 4.78 (dd, J = 9.2; J = 
2.4, 1H); 3.96 (d, J = 2.4, 1H); 2.52 (m, 1H); 2.47 (m, 1H); 2.35 (m, 1H); 2.06 (m, 1H); 1.77 
(m, 1H); 1.71-1.46 (m, 3H); 1.27 (m, 1H). 13C (75.5 MHz, CDCl3) δ: 215.2, 140.7, 128.2, 
127.6, 126.9, 74.5, 57.6, 42.7, 30.7, 27.8, 24.6. Diastereomeric ratio and enantiomeric 
excess determined by chiral GC as reported in the general information, at 130°C, tR is 
13.57 and 14.98 min (major) for the anti diastereomer, 17.29 and 18.77 for the syn 
diastereomer. 
 
 
trans-2-hydroxycyclopentanecarboaldehyde (129), [α]22D = +6.4 (c = 3.0, CHCl3), for 
anti/syn = 7:1. To a suspension of silica gel (15 g) in 10 mL of DCM, 15 mL of a 0.65 M 
solution of NaIO4 in water were added drop-wise. To this suspension, trans-
cyclohexanediol (136, 2 g) was added and the reaction was monitored through TLC (5:1 
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Hexanes/EtOAc) until complete conversion of the starting material, in about 20 min. After 
the filtration of the inorganic precipitates, the organic layer is stirred over Na2SO4 and 
evaporated to provide adipaldehyde 128. This aldehyde (70 mg, 0.6 mmol) is dissolved in 
chloroform and 13.8 of catalyst 104 (0.03 mmoles, 5 mol%) are added. After 5-10 min the 
complete conversion of the starting material is observed on TLC. The selectivity of the 
process is checked through chiral GC without isolating the reaction product (129); at 
100°C, tR is 10.43 and 10.53 min for the anti diastereomer, 12.42 and 13.03 min for the 
syn diastereomer. The organic layer is washed with water, stirred over Na2SO4 and 
evaporated obtaining the clean reaction product. (65 mg, 93%). 129 is not a stable 
product and is reduced to compound 137 using one equiv. of NaBH4 in EtOH at 0°C, in 5-
10 min. for 137, 1H-NMR (300 MHz; CDCl3) δ: 5.30 (brs, 2H); 3.60 (m, 2H); 3.45 (m, 1H); 
1.92 (m, 1H); 1.66 (m, 3H); 1.22 (m, 3H). 
 
 
2-(3-oxo-1-phenylbuthyl) malonic acid diethyl ester (145), [α]22D = +6.1 (c = 0.5, CHCl3). 
1H-NMR (300 MHz; CDCl3) δ: 7.28-7.18 (m, 5H); 4.18 (m, 2H); 3.96 (m, 1H); 3.94 (m, 2H); 
3.69 (d, J = 9.8 Hz, 1H); 2.96 (m, 1H); 2.90 (m, 1H); 2.02 (s, 3H); 1.25 (dd, J = 7.2 Hz, 7.2 Hz, 
3H); 1.01 (dd, J = 7.2 Hz, 7.2 Hz, 3H). (75.5 MHz, CDCl3) δ: 206.1, 168.2, 167.7, 140.4, 
128.5, 128.2, 127.2, 61.7, 61.3, 57.4, 47.4, 40.5, 30.3, 14.0, 13.8. 
    
 
1H-Indene-1,5-(6H)-dione-2,3,7,7a-tetrahydro-7a-methyl (5), [α]22D = +244 (c = 0.5, 
CHCl3), for (S)-enantiomer (83%) ee. 
1H-NMR (300 MHz; CDCl3) δ: 5.96 (s, 1H); 2.95 (m, 
1H); 2.77 (m, 2H); 2.58-2.36 (m, 3H); 2.09 (m, 1H); 1.83 (m, 1H); 1.31 (s, 3H). 13C (75.5 
MHz, CDCl3) δ: 216.5, 198.2, 169.7, 123.9, 48.7, 35.9, 32.9, 29.2, 26.8, 20.6. Enantiomeric 
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excess determined by chiral GC, at 155°C, tR is 5.8 min for (R)-enantiomer, 6.2 min for (S)-
enantiomer and 3.8 min for the starting material.    
 
 
1,6-(2H,7H)-Naphtalenedione-3,4,8,8a-tetrahydro-8a-methyl (56), [α]22D = +107.5 (c = 
2.0, CHCl3), for (S)-enantiomer (92%) ee. 
1H-NMR (300 MHz; CDCl3) δ: 5.85 (s, 1H); 2.75-
2.63 (m, 2H); 2.51-2.38 (m, 4H); 2.18-2.08 (m, 3H); 1.75-164 (m, 1H); 1.44 (s, 3H). 13C (75.5 
MHz, CDCl3) δ: 210.2, 198.0, 165.7, 125.8, 50.5, 37.4, 33.7, 31.8, 29.7, 23.4, 21.0. 
Enantiomeric excess determined by chiral GC, at 140°C, tR is 21.5 min for (R)-enantiomer, 
22.5 min for (S)-enantiomer and 11.2 min for the starting material. 
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